{"meta":{"query_hash":"ceb70015add6","filters":{"venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical"},"cohort_total":84,"direct_labels_cover":0,"predictions_cover":84,"exported":84,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/ceb70015add6","api":"https://metacan.xera.ac/api/v1/cohort?venue=Multiple+Sclerosis+Journal+-+Experimental+Translational+and+Clinical"},"results":[{"id":"W1825100754","doi":"10.1177/2055217315596532","title":"Association of plasma levels of Protein S with disease severity in multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Neurosciences Foundation; Royal Melbourne Hospital Neuroscience Foundation; Hospital Research Foundation; Ministère de la Santé et des Services sociaux; Neurosciences Research Foundation","keywords":"MERTK; Multiple sclerosis; Cohort; Disease; Medicine; Internal medicine; Oncology; Immune system; Immunology; Clinically isolated syndrome; Receptor; Case-control study; Innate immune system; Receptor tyrosine kinase","score_opus":0.15821249407229257,"score_gpt":0.30927449500461335,"score_spread":0.15106200093232078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1825100754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99688447,0.0018708338,0.00015533724,0.00043487665,0.00016725899,0.0003059926,0.00014104434,0.000009548561,0.000030643405],"genre_scores_gemma":[0.9989321,0.000077052915,0.00079522474,0.000021212178,0.000037129954,0.000015960652,0.000041627147,0.000013602086,0.00006606654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793553,0.00041430144,0.0009930254,0.00023549097,0.00020449936,0.00021713319],"domain_scores_gemma":[0.99873513,0.0003660396,0.00050482294,0.000109138826,0.00017959028,0.00010529761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009188689,0.00017219647,0.00045115748,0.00010003798,0.000108915025,0.000017063496,0.00011947229,0.00019807125,0.000092211325],"category_scores_gemma":[0.0002321833,0.00014148699,0.00017068375,0.00013750054,0.00024857602,0.00032003244,0.00003045439,0.00031701374,0.000005115702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033550737,0.0014576433,0.6005694,0.000014906466,0.00022637262,8.48955e-7,0.0005659513,0.0001444065,0.38924426,0.00007490944,0.000041553223,0.004304673],"study_design_scores_gemma":[0.01136535,0.0004312077,0.852007,0.00026452373,0.000045209665,0.0000062099316,0.00032997367,0.0005766413,0.13458668,0.00011959236,0.00011189818,0.00015573185],"about_ca_topic_score_codex":0.00006196804,"about_ca_topic_score_gemma":0.000052432064,"teacher_disagreement_score":0.25465757,"about_ca_system_score_codex":0.00007629697,"about_ca_system_score_gemma":0.00014136311,"threshold_uncertainty_score":0.5769672},"labels":[],"label_agreement":null},{"id":"W2126609777","doi":"10.1177/2055217315585333","title":"Adherence to behavioural interventions in multiple sclerosis: Follow-up meeting report (AD@MS-2)","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Psychological intervention; Psychosocial; Physical activity; Multiple sclerosis; Intervention (counseling); Psychology; Medicine; Clinical psychology; Gerontology; Physical therapy; Psychiatry","score_opus":0.5241701693713542,"score_gpt":0.44977806851876634,"score_spread":0.07439210085258785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126609777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911819,0.0029461258,0.0004870288,0.0029591029,0.00095488236,0.0010432315,0.00006495337,0.00007251242,0.00029026024],"genre_scores_gemma":[0.9867361,0.0005745834,0.011474721,0.00028373394,0.0003809393,0.00017712715,0.000068513735,0.000057538608,0.00024673346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940182,0.0004346079,0.0025240711,0.0008406856,0.0014215859,0.00076086854],"domain_scores_gemma":[0.9964675,0.0007580028,0.00037605249,0.00034464302,0.0005114471,0.0015424027],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002984902,0.00044841587,0.0009638238,0.00036763542,0.0004701116,0.00019809598,0.00029230744,0.00025408188,0.0001901709],"category_scores_gemma":[0.003091359,0.0003957676,0.00084079424,0.0004641052,0.0004079851,0.0005129528,0.00022658227,0.0011286587,0.00005623951],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026410145,0.0024064071,0.9444114,0.00004223879,0.00026237985,0.00014076341,0.0025211237,0.00006670642,0.033069648,0.000012867982,0.0011714568,0.013254018],"study_design_scores_gemma":[0.019895406,0.0019401569,0.9654371,0.002434799,0.00010827032,0.00031239504,0.003610738,0.001684608,0.00362448,0.000052995954,0.00042975022,0.00046930116],"about_ca_topic_score_codex":0.00049334794,"about_ca_topic_score_gemma":0.0010846563,"teacher_disagreement_score":0.02944517,"about_ca_system_score_codex":0.00026886901,"about_ca_system_score_gemma":0.00025600186,"threshold_uncertainty_score":0.99984944},"labels":[],"label_agreement":null},{"id":"W2167256476","doi":"10.1177/2055217315577829","title":"Personalized activity index, a new safety monitoring tool for multiple sclerosis clinical trials","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Multiple Sclerosis Society of Canada","keywords":"Medicine; Guideline; Multiple sclerosis; Clinical trial; Post-hoc analysis; Internal medicine; Oncology; Pathology; Psychiatry","score_opus":0.6189445089244806,"score_gpt":0.5053682196332013,"score_spread":0.11357628929127928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167256476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97123635,0.003936578,0.014279302,0.0056765,0.0018536688,0.0025548448,0.00024830532,0.00012132737,0.00009313198],"genre_scores_gemma":[0.97000945,0.0037643414,0.020338506,0.00030023436,0.0050495854,0.00014464374,0.000048169506,0.00009052936,0.00025454827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9909513,0.0018549112,0.0035228534,0.0010522786,0.0017278877,0.0008907909],"domain_scores_gemma":[0.985645,0.010358843,0.0008054309,0.00038430723,0.0006388184,0.00216763],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.012860675,0.00063501304,0.0023540263,0.00022279816,0.0008100264,0.00028418904,0.00032105565,0.000565181,0.00018246591],"category_scores_gemma":[0.014112846,0.0005120264,0.002038411,0.0002863209,0.0007848502,0.0006729344,0.00016427571,0.0014738805,0.000024277357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034747846,0.0030835357,0.77246886,0.00004904477,0.0016027937,0.00000994768,0.0009600816,0.00004577592,0.032233264,0.00004676934,0.0031308027,0.15162127],"study_design_scores_gemma":[0.075656846,0.0022577154,0.9004511,0.0006656886,0.00037066595,0.000058694237,0.0012043867,0.007926419,0.0053499597,0.00015855116,0.0052543697,0.0006455739],"about_ca_topic_score_codex":0.00010682191,"about_ca_topic_score_gemma":0.000023537252,"teacher_disagreement_score":0.1509757,"about_ca_system_score_codex":0.00027538784,"about_ca_system_score_gemma":0.00085987506,"threshold_uncertainty_score":0.99973315},"labels":[],"label_agreement":null},{"id":"W2200581100","doi":"10.1177/2055217315600193","title":"Multiple sclerosis in Latin America: A different disease course severity? A collaborative study from the MSBase Registry","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Cégep de Lévis; Hôpital Charles-Le Moyne; Hôpital Notre-Dame","funders":"EMD Serono; H. Lundbeck A/S; Novartis Pharma; Multiple Sclerosis Society; Sanofi; Guthy-Jackson Charitable Foundation; Canadian Institutes of Health Research; Ministère de la Santé et des Services sociaux; Teva Pharmaceutical Industries; Biogen","keywords":"Multiple sclerosis; Latin Americans; Medicine; Demography; Disease; Internal medicine; Psychiatry","score_opus":0.23030205205927265,"score_gpt":0.3950978019146475,"score_spread":0.16479574985537485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2200581100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98468167,0.004388845,0.00011184747,0.007931456,0.00032820055,0.0017617167,0.0007020737,0.000047635775,0.000046573787],"genre_scores_gemma":[0.9956152,0.0012546896,0.0012622501,0.000714762,0.0006962805,0.000235618,0.00013008382,0.000051430827,0.000039691626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943078,0.0011762866,0.0014833887,0.00081893447,0.0016196944,0.00059388817],"domain_scores_gemma":[0.9947699,0.0026366806,0.00035441725,0.00047573596,0.00039082151,0.0013724763],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001110441,0.0005184983,0.0009859288,0.000107796324,0.0005712399,0.00023278999,0.00033935742,0.00015074735,0.00014593409],"category_scores_gemma":[0.0017919363,0.00034915234,0.00038591996,0.00047181488,0.0009109495,0.0003537237,0.0002052243,0.0012275239,0.000021441785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067012035,0.008645634,0.9696612,0.000009108184,0.0005097932,0.00007669311,0.0051196907,0.000083553066,0.0023531376,0.000006078351,0.0012901413,0.005543811],"study_design_scores_gemma":[0.024434652,0.0010740431,0.9470487,0.0003958717,0.0001878025,0.000007173325,0.020143958,0.005712887,0.00022632368,0.000061386716,0.00035141155,0.00035575693],"about_ca_topic_score_codex":0.00048695257,"about_ca_topic_score_gemma":0.00067762507,"teacher_disagreement_score":0.022612423,"about_ca_system_score_codex":0.00021741813,"about_ca_system_score_gemma":0.00045057677,"threshold_uncertainty_score":0.99989605},"labels":[],"label_agreement":null},{"id":"W2243670870","doi":"10.1177/2055217315589775","title":"Evolving role of MRI in optimizing the treatment of multiple sclerosis: Canadian Consensus recommendations","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Queen Elizabeth II Health Sciences Centre; Centre Hospitalier de l’Université de Montréal; Foothills Medical Centre; McGill University Health Centre; St. Michael's Hospital; University of British Columbia; University of Ottawa; Montreal Neurological Institute and Hospital","funders":"Canadian Institutes of Health Research; Novartis Pharmaceuticals Canada; Multiple Sclerosis Society of Canada; Vertex Pharmaceuticals; Teva Pharmaceutical Industries","keywords":"Medicine; Multiple sclerosis; Magnetic resonance imaging; Neuroimaging; Radiological weapon; Atrophy; Radiology; Pathology; Psychiatry","score_opus":0.2636027957651652,"score_gpt":0.3891455065218893,"score_spread":0.12554271075672407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2243670870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832309,0.008411639,0.000050197094,0.0068407743,0.00023289036,0.0007336109,0.00014955089,0.000012650438,0.00033779655],"genre_scores_gemma":[0.98544323,0.0050769635,0.00909042,0.00008430837,0.00018953985,0.000045755056,0.000030380086,0.00002501836,0.000014377902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969503,0.00035345374,0.0013707083,0.00032409502,0.0005839206,0.00041748772],"domain_scores_gemma":[0.9970567,0.0014271183,0.00027716736,0.00022149227,0.00035771282,0.00065980974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010473179,0.00025025022,0.0006679054,0.0002676818,0.00029207685,0.00004297383,0.00015129847,0.00013994137,0.00010818619],"category_scores_gemma":[0.00046368342,0.00017887248,0.00034048953,0.0002724116,0.0005557263,0.00014181183,0.000032279597,0.00036045592,0.0000038389926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014903108,0.0034263511,0.91434425,0.000022334449,0.00063643156,0.0000072613952,0.01162079,0.0006860701,0.04280336,0.000067188674,0.00056700484,0.024328666],"study_design_scores_gemma":[0.019497564,0.0020524687,0.9132,0.0007300488,0.000121907695,0.000040997733,0.023114672,0.025327122,0.0139314355,0.000095133946,0.001610835,0.00027780072],"about_ca_topic_score_codex":0.009552425,"about_ca_topic_score_gemma":0.012232492,"teacher_disagreement_score":0.028871924,"about_ca_system_score_codex":0.0002761827,"about_ca_system_score_gemma":0.00048037132,"threshold_uncertainty_score":0.9970431},"labels":[],"label_agreement":null},{"id":"W2246215802","doi":"10.1177/2055217315588223","title":"Cannabis-induced alterations in brain activation during a test of information processing speed in patients with MS","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Cannabis; Effects of cannabis; Neuropsychology; Medicine; Anterior cingulate cortex; Audiology; Psychology; Neuroscience; Internal medicine; Psychiatry; Cognition; Cannabidiol","score_opus":0.12353141375967759,"score_gpt":0.3634025330788602,"score_spread":0.23987111931918265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2246215802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99725634,0.000050483843,0.00009071184,0.0018998975,0.000035875662,0.00055495964,0.000016408612,0.000009732669,0.00008561395],"genre_scores_gemma":[0.9985271,0.000017230905,0.0012000436,0.000092601964,0.000077643745,0.000018571069,0.00004970494,0.000011743033,0.000005356842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978238,0.00010676285,0.0009732816,0.00018045187,0.0006892437,0.00022649391],"domain_scores_gemma":[0.99891603,0.00023041919,0.00022667053,0.000078166144,0.00031936422,0.00022937519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005886137,0.00015601997,0.0003494314,0.00029396728,0.00011563169,0.000056660632,0.00006225652,0.000090125184,0.000016011327],"category_scores_gemma":[0.00082286843,0.00012422138,0.00006601257,0.00031336868,0.00012407119,0.0010016024,0.000025465219,0.00040380785,0.0000014552177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024703967,0.0014103325,0.9693794,0.000035015677,0.000030290441,0.0000011259411,0.0027004236,0.00017561956,0.020021006,0.0000052366718,0.00001750748,0.003753638],"study_design_scores_gemma":[0.020219598,0.00081525993,0.9671213,0.00055500795,0.000008579074,0.000004484808,0.0008989054,0.0035347594,0.0066964775,0.000012490372,0.000010705346,0.00012243744],"about_ca_topic_score_codex":0.000159145,"about_ca_topic_score_gemma":0.000126291,"teacher_disagreement_score":0.0177492,"about_ca_system_score_codex":0.00015303087,"about_ca_system_score_gemma":0.00020711617,"threshold_uncertainty_score":0.5065601},"labels":[],"label_agreement":null},{"id":"W2292463500","doi":"10.1177/2055217315618687","title":"A randomized trial of teriflunomide added to glatiramer acetate in relapsing multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ottawa Hospital; University of Ottawa","funders":"American Academy of Neurology","keywords":"Teriflunomide; Tolerability; Glatiramer acetate; Medicine; Placebo; Adverse effect; Multiple sclerosis; Internal medicine; Randomized controlled trial; Gastroenterology; Pharmacology; Immunology; Pathology; Fingolimod","score_opus":0.314488366734042,"score_gpt":0.41618649477243236,"score_spread":0.10169812803839035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2292463500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991256,0.0015903007,0.0005659708,0.0031697704,0.00057488016,0.002431194,0.000051913412,0.000035540266,0.00032445617],"genre_scores_gemma":[0.9828552,0.0011059823,0.014840202,0.00036167106,0.00052635337,0.00017146042,0.000027194726,0.000053606873,0.00005831011],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99378866,0.0010073709,0.0026603958,0.0006396776,0.0012985702,0.0006053206],"domain_scores_gemma":[0.99518,0.0026625623,0.00043211618,0.00028797679,0.00037056964,0.0010667737],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0042744945,0.0004296707,0.0018932504,0.0004268772,0.00020929125,0.00010248422,0.00022558671,0.00024157325,0.000116798125],"category_scores_gemma":[0.0041964855,0.0003435342,0.0007977226,0.0004285558,0.0007711371,0.0003746446,0.00014415436,0.0008289512,0.000021479535],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87271106,0.0026120069,0.056229305,0.000028651468,0.00043943943,0.000013468775,0.002874813,0.0001500351,0.053686824,0.000038354814,0.00032641258,0.01088962],"study_design_scores_gemma":[0.86859614,0.0018661021,0.11483876,0.00089434895,0.0001275206,0.00002677511,0.0012500383,0.005797277,0.005906666,0.00012273535,0.00021970716,0.00035395444],"about_ca_topic_score_codex":0.00019668296,"about_ca_topic_score_gemma":0.00007595192,"teacher_disagreement_score":0.058609452,"about_ca_system_score_codex":0.00015597542,"about_ca_system_score_gemma":0.00026861092,"threshold_uncertainty_score":0.99990165},"labels":[],"label_agreement":null},{"id":"W2336694595","doi":"10.1177/2055217316634111","title":"Delayed-release dimethyl fumarate and disability assessed by the Multiple Sclerosis Functional Composite: Integrated analysis of DEFINE and CONFIRM","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"Marshall Space Flight Center; Biogen","keywords":"Dimethyl fumarate; Multiple sclerosis; Composite number; Psychology; Physical medicine and rehabilitation; Medicine; Chemistry; Materials science; Immunology; Composite material","score_opus":0.15989945607919162,"score_gpt":0.36311883009111656,"score_spread":0.20321937401192494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336694595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881599,0.0041332687,0.0017423232,0.004538588,0.0001141862,0.0005157253,0.0007403589,0.000028181692,0.000027477983],"genre_scores_gemma":[0.99436325,0.003834314,0.001215747,0.00022896171,0.00011997256,0.000045750832,0.00012691677,0.00002813694,0.000036940768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99609554,0.00056711823,0.0013965161,0.00066237716,0.00086529035,0.0004131862],"domain_scores_gemma":[0.99375117,0.004687749,0.00034194242,0.00027032616,0.00035803675,0.000590757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013938306,0.00039361187,0.0010089808,0.0001592677,0.000636111,0.00011020047,0.00014510343,0.00019706007,0.00035194942],"category_scores_gemma":[0.00068836234,0.0002228386,0.00047922067,0.00047677223,0.0023995286,0.00031544856,0.00012351703,0.0005292219,0.0000029544697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028866527,0.0013050303,0.6310426,0.000017328512,0.0022997009,0.0000013401868,0.00016812097,0.00001190964,0.3422271,0.000036698788,0.00024145033,0.019762073],"study_design_scores_gemma":[0.011105903,0.00068258337,0.9661843,0.00018851877,0.00090747577,0.00002398698,0.0005151042,0.006432592,0.013433109,0.00003642125,0.00022821964,0.00026177624],"about_ca_topic_score_codex":0.00036110976,"about_ca_topic_score_gemma":0.00020152816,"teacher_disagreement_score":0.33514172,"about_ca_system_score_codex":0.00008310423,"about_ca_system_score_gemma":0.00008172862,"threshold_uncertainty_score":0.9087094},"labels":[],"label_agreement":null},{"id":"W2403913513","doi":"10.1177/2055217316649981","title":"Erythrocytes in multiple sclerosis – forgotten contributors to the pathophysiology?","year":2016,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Trish Multiple Sclerosis Research Foundation; Hunter Medical Research Institute; Multiple Sclerosis Australia; Canadian Institutes of Health Research; Bond University","keywords":"Multiple sclerosis; Disease; Autoimmunity; Pathological; Myelin; Genetic predisposition; Immune system; Immunology; Pathophysiology; Experimental autoimmune encephalomyelitis; Autoimmune disease; Medicine; Neuroscience; Central nervous system; Pathology; Biology","score_opus":0.20962813595600904,"score_gpt":0.3783915462416644,"score_spread":0.16876341028565534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403913513","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01380955,0.97973,0.00020964039,0.0025254583,0.0016049034,0.0016545901,0.0003677679,0.000049587965,0.000048519472],"genre_scores_gemma":[0.042922474,0.95210195,0.00070848205,0.0017310254,0.0019788644,0.00020727476,0.00016078618,0.00008202837,0.00010711809],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99499124,0.0008333428,0.0022039227,0.0008498461,0.00048335717,0.0006383175],"domain_scores_gemma":[0.995365,0.0029956535,0.0005138893,0.00037380648,0.00014589108,0.0006057231],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009977263,0.0006799355,0.0024476098,0.00028512132,0.00048748567,0.00007522585,0.00031739546,0.000728045,0.00038257006],"category_scores_gemma":[0.0005140242,0.00038264692,0.0014557652,0.0003417357,0.00045152588,0.00016986458,0.00012213133,0.0013490381,0.00023408384],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021224837,0.0015456331,0.005114958,0.00053518865,0.0007530534,0.00004463054,0.00031649883,0.000005784325,0.00203528,0.00010901237,0.0023972339,0.9850202],"study_design_scores_gemma":[0.015044005,0.0026159117,0.053038836,0.019791018,0.00074467197,0.0004349354,0.00034691687,0.00012338701,0.000121015415,0.00023257501,0.90637606,0.0011306915],"about_ca_topic_score_codex":0.000018104827,"about_ca_topic_score_gemma":0.000032031057,"teacher_disagreement_score":0.9838896,"about_ca_system_score_codex":0.00017216966,"about_ca_system_score_gemma":0.00030648502,"threshold_uncertainty_score":0.99986255},"labels":[],"label_agreement":null},{"id":"W2415546685","doi":"10.1177/2055217316653150","title":"Distractibility in multiple sclerosis: The role of depression","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; Health Sciences Centre; University of Toronto; Carleton University; Sunnybrook Health Science Centre","funders":"","keywords":"Depression (economics); Anxiety; Psychology; Hospital Anxiety and Depression Scale; Multiple sclerosis; Cognition; Clinical psychology; Developmental psychology; Psychiatry","score_opus":0.18417794540964375,"score_gpt":0.379125427741175,"score_spread":0.19494748233153128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415546685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99207914,0.0041203112,0.0001675032,0.0026150504,0.00015443604,0.0005787913,0.000076981516,0.000021238318,0.00018652708],"genre_scores_gemma":[0.99569523,0.002800078,0.0010398121,0.00008933609,0.0002784799,0.000045867,0.0000072514567,0.000025724337,0.000018241006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99639094,0.00041261557,0.0013868584,0.00049667835,0.000885553,0.00042735907],"domain_scores_gemma":[0.9960798,0.0027857977,0.00028155028,0.00031523447,0.00017933325,0.0003582961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015530521,0.00026958543,0.00060178863,0.000113702336,0.0003467525,0.000043084776,0.0002279434,0.00017803871,0.00022560812],"category_scores_gemma":[0.0011553081,0.00014254161,0.00042471642,0.00018703914,0.0009169534,0.00034543395,0.00011318913,0.000588888,0.000010779122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001601921,0.0011750356,0.6505422,0.0000103028,0.00009611193,0.0000021568576,0.00026861115,0.0000037054087,0.28375363,0.000026442183,0.000029926676,0.062489964],"study_design_scores_gemma":[0.009251505,0.00034340948,0.9284421,0.0006955972,0.000036541285,0.00002812614,0.0009580351,0.0007171545,0.058779746,0.00024412607,0.00034018361,0.00016343048],"about_ca_topic_score_codex":0.000102704944,"about_ca_topic_score_gemma":0.000111894115,"teacher_disagreement_score":0.27789995,"about_ca_system_score_codex":0.00008713396,"about_ca_system_score_gemma":0.00010562402,"threshold_uncertainty_score":0.58126783},"labels":[],"label_agreement":null},{"id":"W2466340424","doi":"10.1177/2055217316657116","title":"Cognitive evolution in natalizumab-treated multiple sclerosis patients","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Clinique Neuro-Outaouais","funders":"","keywords":"Natalizumab; Multiple sclerosis; Medicine; Cognition; Oncology; Psychiatry","score_opus":0.16508463180883598,"score_gpt":0.37209468421428116,"score_spread":0.20701005240544518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466340424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99510354,0.001285417,0.0005035636,0.001435052,0.00027039676,0.0009109794,0.0002545056,0.000057823883,0.00017873329],"genre_scores_gemma":[0.9964768,0.0019302919,0.00077556615,0.00019042083,0.00034774386,0.00008820257,0.0000732269,0.00005241409,0.0000652766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955665,0.00042768943,0.0014650574,0.0007381546,0.001119096,0.00068352686],"domain_scores_gemma":[0.99643016,0.0020044455,0.0002620653,0.00018926045,0.00045857974,0.00065549056],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008210302,0.00042521794,0.00075371517,0.0003391306,0.0004460859,0.00007977344,0.00016322818,0.00027896918,0.00034337686],"category_scores_gemma":[0.0015797334,0.00029395186,0.00044597292,0.0003383921,0.0007264641,0.0006136397,0.000111144094,0.00060524605,0.00006830349],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037312345,0.0025923734,0.92527723,0.000017069031,0.00025593856,0.000012060278,0.0002663541,0.0000017955199,0.03924614,0.00003124832,0.00012698675,0.028441565],"study_design_scores_gemma":[0.036674943,0.00105823,0.9523658,0.001431465,0.00006799739,0.000022124725,0.00044570412,0.0005051373,0.0069145476,0.00006777281,0.00009756803,0.0003487106],"about_ca_topic_score_codex":0.00012607843,"about_ca_topic_score_gemma":0.00012688714,"teacher_disagreement_score":0.032943707,"about_ca_system_score_codex":0.00034018024,"about_ca_system_score_gemma":0.00012607325,"threshold_uncertainty_score":0.99995124},"labels":[],"label_agreement":null},{"id":"W2512072495","doi":"10.1177/2055217316666406","title":"Prognostic factors for long-term outcomes in relapsing–remitting multiple sclerosis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Javna Agencija za Raziskovalno Dejavnost RS; Neuroscience Research Australia; Teva Pharmaceutical Industries","keywords":"Medicine; Proportional hazards model; Internal medicine; Stepwise regression; Univariate; Univariate analysis; Multiple sclerosis; Multivariate analysis; Relapsing remitting; Post-hoc analysis; Multivariate statistics; Disease","score_opus":0.2925809029787263,"score_gpt":0.4110410526671394,"score_spread":0.11846014968841312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2512072495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99125683,0.0013084606,0.0016240551,0.003638025,0.00049364596,0.0014429807,0.00013410361,0.00006828278,0.000033638487],"genre_scores_gemma":[0.9932711,0.001579682,0.004169616,0.00018218567,0.00042963368,0.00015247984,0.000037538903,0.00007506823,0.00010268491],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99540526,0.000266262,0.0017888403,0.00078450626,0.00091574393,0.00083941885],"domain_scores_gemma":[0.9913061,0.007182564,0.00032857567,0.00025283208,0.00025567174,0.00067423907],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012728313,0.00049796,0.0010525384,0.00029293005,0.00057892565,0.00012789703,0.00023153973,0.0002924652,0.00016635112],"category_scores_gemma":[0.0037964152,0.00032021347,0.00076577044,0.00020720942,0.00057381147,0.00051757,0.00010614867,0.0006092248,0.000013451714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012649824,0.0016052476,0.90865827,0.000043538836,0.00031670986,0.0000071778363,0.00049383356,0.00000324752,0.0674029,0.00002013213,0.00005993288,0.020124054],"study_design_scores_gemma":[0.02100385,0.0008550463,0.9681735,0.0015944726,0.00009253706,0.000024232011,0.00044548966,0.00041892586,0.0068960213,0.000055066423,0.00004779415,0.00039307543],"about_ca_topic_score_codex":0.000024507866,"about_ca_topic_score_gemma":0.00008931905,"teacher_disagreement_score":0.060506877,"about_ca_system_score_codex":0.00020004311,"about_ca_system_score_gemma":0.00013527641,"threshold_uncertainty_score":0.999925},"labels":[],"label_agreement":null},{"id":"W2512341706","doi":"10.1177/2055217316666093","title":"Multiple sclerosis in First Nations Canadians: A pilot comparison study","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Manitoba","funders":"Ministry of Economy, Trade and Industry; Multiple Sclerosis Society","keywords":"Ethnic group; Multiple sclerosis; Observational study; Medicine; Odds; Odds ratio; Statistical significance; Internal medicine; Demography; Clinical psychology; Psychiatry; Logistic regression","score_opus":0.28255504074704574,"score_gpt":0.40361573542825513,"score_spread":0.12106069468120939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2512341706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872478,0.0014800619,0.00027083684,0.008735673,0.0003428705,0.0014571922,0.00013425817,0.000055432156,0.0002758236],"genre_scores_gemma":[0.9956112,0.0019039497,0.0014823865,0.00020455159,0.00045039522,0.00019101855,0.000017166907,0.00005304586,0.00008626915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951784,0.00041998108,0.001821496,0.0007426931,0.0011189198,0.00071850687],"domain_scores_gemma":[0.99458367,0.0037352713,0.00024615254,0.000299276,0.00024855413,0.0008871049],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012845797,0.00042088862,0.00091463584,0.00052280654,0.00097456813,0.0001274007,0.00026070076,0.00015912172,0.0004328757],"category_scores_gemma":[0.0017117574,0.00030081626,0.0003418584,0.00048185332,0.00054737134,0.00046109612,0.00010369697,0.00069001265,0.0000488094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018023428,0.0070039006,0.9647713,0.000019753174,0.0003358456,0.000021736794,0.0014888541,0.000024483119,0.015142087,0.00004137435,0.0003550289,0.008993313],"study_design_scores_gemma":[0.028198581,0.0025237221,0.96197295,0.0008450763,0.00006921378,0.000028562745,0.002968344,0.0012975254,0.00090541143,0.000023188484,0.0008046809,0.00036274045],"about_ca_topic_score_codex":0.0020120703,"about_ca_topic_score_gemma":0.043019947,"teacher_disagreement_score":0.041007876,"about_ca_system_score_codex":0.00032584224,"about_ca_system_score_gemma":0.00022525262,"threshold_uncertainty_score":0.9999444},"labels":[],"label_agreement":null},{"id":"W2550262071","doi":"10.1177/2055217316680638","title":"Coping strategies in relation to negative work events and accommodations in employed multiple sclerosis patients","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Genentech; ZonMw; Mallinckrodt Pharmaceuticals; Biogen","keywords":"Coping (psychology); Presenteeism; Psychology; Absenteeism; Demographics; Clinical psychology; Cognition; Multiple sclerosis; Job loss; Sick leave; Medicine; Physical therapy; Social psychology; Psychiatry; Unemployment","score_opus":0.19331978171828573,"score_gpt":0.38829531481398183,"score_spread":0.1949755330956961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550262071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936213,0.0003347937,0.0006103403,0.0041452786,0.00015954731,0.0009911476,0.0000577287,0.000025421437,0.000054427157],"genre_scores_gemma":[0.99429446,0.0011165298,0.004054206,0.00021457014,0.00014008716,0.00010736022,0.000023041592,0.00003288904,0.000016855827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966135,0.00037337764,0.0012912437,0.0005646789,0.0006814295,0.00047577498],"domain_scores_gemma":[0.99698263,0.0020363643,0.00018220811,0.00015940466,0.00018215888,0.00045723308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007982845,0.00030603295,0.00058736023,0.00037944803,0.00031462352,0.000093537055,0.00012741194,0.00018229194,0.00008134583],"category_scores_gemma":[0.0011087651,0.0002297859,0.00016078689,0.00043250367,0.00026623634,0.00079664396,0.00011505537,0.000505075,0.000014287958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017514502,0.0010741644,0.96730787,0.000012252826,0.00008202348,0.0000025363163,0.0014470201,0.000053446653,0.011934634,0.00003394554,0.00006261063,0.016238036],"study_design_scores_gemma":[0.017484197,0.0005064422,0.97804797,0.0014743675,0.000018987288,0.0000032466287,0.0008694723,0.00027340645,0.00081119424,0.00020927562,0.000044357617,0.00025710865],"about_ca_topic_score_codex":0.00009721917,"about_ca_topic_score_gemma":0.00033005775,"teacher_disagreement_score":0.015980927,"about_ca_system_score_codex":0.00020464082,"about_ca_system_score_gemma":0.000099962,"threshold_uncertainty_score":0.93703973},"labels":[],"label_agreement":null},{"id":"W2553060585","doi":"10.1177/2055217316676644","title":"Improvement in relapse recovery with peginterferon beta-1a in patients with multiple sclerosis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Multiple sclerosis; Internal medicine; Placebo; Post-hoc analysis; Gastroenterology; Psychiatry; Pathology","score_opus":0.09819724325926502,"score_gpt":0.3219276521096802,"score_spread":0.2237304088504152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553060585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944895,0.0004294561,0.00029427675,0.0033187189,0.00015641186,0.0011104038,0.00008818498,0.000029757059,0.00008329747],"genre_scores_gemma":[0.99540263,0.0010712775,0.002798327,0.00027800072,0.0001812007,0.00011630264,0.000030758274,0.00006284467,0.00005862656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99570656,0.00023301112,0.0013950944,0.0007980231,0.0011488913,0.0007184224],"domain_scores_gemma":[0.9976501,0.0010360742,0.00027614538,0.00028838016,0.00022494559,0.0005243411],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008774015,0.00046587348,0.0008627809,0.00035280432,0.000228221,0.00008613632,0.0001902186,0.00019585546,0.00021367372],"category_scores_gemma":[0.00021087425,0.00027306564,0.00024887742,0.0002979077,0.00054509734,0.000652849,0.00009289714,0.0007399416,0.0000163665],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01752963,0.0032296577,0.9285468,0.000024007248,0.00026370943,0.000015453988,0.00042397552,0.000027979977,0.0168414,0.000008418636,0.000065773056,0.033023223],"study_design_scores_gemma":[0.049912844,0.0063325483,0.937223,0.0018571151,0.000044031887,0.000010412319,0.00036983026,0.00018932682,0.0035429199,0.000013671742,0.00012319893,0.00038109478],"about_ca_topic_score_codex":0.00010993235,"about_ca_topic_score_gemma":0.00047335145,"teacher_disagreement_score":0.032642126,"about_ca_system_score_codex":0.00034295733,"about_ca_system_score_gemma":0.000143709,"threshold_uncertainty_score":0.99997216},"labels":[],"label_agreement":null},{"id":"W2586478668","doi":"10.1177/2055217317690561","title":"Noninvasive tongue stimulation combined with intensive cognitive and physical rehabilitation induces neuroplastic changes in patients with multiple sclerosis: A multimodal neuroimaging study","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University; Montreal Neurological Institute and Hospital","funders":"Concordia University; McGill University","keywords":"Working memory; Physical medicine and rehabilitation; Premotor cortex; Neuroplasticity; Psychology; Neuromodulation; Medicine; Neuroimaging; Multiple sclerosis; Transcranial direct-current stimulation; Functional magnetic resonance imaging; Dorsolateral prefrontal cortex; Rehabilitation; Cognition; Neuroscience; Stimulation; Prefrontal cortex","score_opus":0.1101354382697149,"score_gpt":0.3611037731074665,"score_spread":0.2509683348377516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586478668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959138,0.00008935623,0.000056134515,0.00140391,0.00011638098,0.0023173464,0.00006173799,0.000030449131,0.000010893994],"genre_scores_gemma":[0.9984421,0.00009283188,0.0008796803,0.00014888274,0.00019716167,0.00013796659,0.00004258279,0.000055681612,0.0000031273744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965972,0.00041394908,0.0007059872,0.00082605984,0.0010013871,0.00045541773],"domain_scores_gemma":[0.9951618,0.0028479355,0.00043497246,0.0002500173,0.0008908297,0.00041449867],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048510818,0.000455275,0.00083898916,0.00024521557,0.001011488,0.00030175585,0.00015107324,0.00009942352,0.00001195887],"category_scores_gemma":[0.002295729,0.00033184403,0.00011952626,0.00014623713,0.0011098315,0.0007464492,0.0001418745,0.0008727696,0.0000024955202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014628995,0.004565751,0.9639984,0.000032059634,0.00030996237,0.000033984674,0.0055749263,0.000070477014,0.004151927,0.0000026358343,0.0000034077066,0.0066275154],"study_design_scores_gemma":[0.05011267,0.013172409,0.91836345,0.0010622516,0.00017960074,0.000016379221,0.0073195305,0.0088754045,0.00055795076,0.0000075664066,8.316571e-7,0.0003319619],"about_ca_topic_score_codex":0.0001223733,"about_ca_topic_score_gemma":0.00041722477,"teacher_disagreement_score":0.04563491,"about_ca_system_score_codex":0.00007078959,"about_ca_system_score_gemma":0.00008813948,"threshold_uncertainty_score":0.99991333},"labels":[],"label_agreement":null},{"id":"W2623186536","doi":"10.1177/2055217317713027","title":"Cannabis and cognitive functioning in multiple sclerosis: The role of gender","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Multiple Sclerosis Society","keywords":"Cannabis; Psychology; Cognition; Recall; California Verbal Learning Test; Effects of cannabis; Effects of sleep deprivation on cognitive performance; Verbal memory; Verbal learning; Clinical psychology; Psychiatry; Developmental psychology; Audiology; Medicine; Cannabidiol","score_opus":0.16839586832298536,"score_gpt":0.3693324806192172,"score_spread":0.20093661229623183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623186536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879179,0.0066820513,0.000049879898,0.004428125,0.00014570924,0.00036006875,0.000037400623,0.0000068428317,0.00037202906],"genre_scores_gemma":[0.99848795,0.0006696384,0.00018281743,0.00018753964,0.00027605973,0.00003805622,0.000008621026,0.000019652347,0.00012967503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811023,0.00014098908,0.0006795093,0.00030636427,0.00048749126,0.0002754287],"domain_scores_gemma":[0.9989942,0.00016059846,0.00022377551,0.00017117393,0.00017149761,0.0002787668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008767689,0.00017244875,0.00037015427,0.00008841032,0.000823087,0.0001551998,0.00013118768,0.00013241584,0.00013021375],"category_scores_gemma":[0.00036817242,0.00012178162,0.00021442973,0.00006493616,0.0008486043,0.00025692797,0.00007604599,0.0006011219,0.0000022562465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017794647,0.00067784154,0.91849613,0.000018513707,0.0001785513,0.0000066569824,0.0012809213,0.000006384698,0.032487333,0.00013362014,0.00020113021,0.044733435],"study_design_scores_gemma":[0.0075473436,0.00038028724,0.977758,0.0002758602,0.00006882393,0.00007376002,0.003906418,0.0020321747,0.007020909,0.0002092916,0.0005941954,0.00013296797],"about_ca_topic_score_codex":0.0002918132,"about_ca_topic_score_gemma":0.00014106327,"teacher_disagreement_score":0.05926182,"about_ca_system_score_codex":0.000028129125,"about_ca_system_score_gemma":0.00012834145,"threshold_uncertainty_score":0.63306034},"labels":[],"label_agreement":null},{"id":"W2752881099","doi":"10.1177/2055217317728301","title":"Which symptoms contribute the most to patients’ perception of health in multiple sclerosis?","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Multiple sclerosis; Medicine; Disease; Physical therapy; Perception; Clinical psychology; Psychology; Psychiatry; Internal medicine","score_opus":0.1878634042181931,"score_gpt":0.40003885592101746,"score_spread":0.21217545170282437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752881099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97832215,0.0007089373,0.0002541509,0.018807556,0.00034745294,0.0012758365,0.00017515934,0.00001706938,0.000091688],"genre_scores_gemma":[0.9953083,0.0022696452,0.001223794,0.00072005554,0.00030872604,0.00006321671,0.000055951874,0.000032918066,0.000017436809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99572426,0.00046307134,0.0017356339,0.000521096,0.00097354373,0.0005823955],"domain_scores_gemma":[0.9970044,0.00091912865,0.0005701555,0.00046523588,0.0005092797,0.0005318394],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0023691617,0.0003141397,0.00089458056,0.0001664875,0.0014678709,0.0001841341,0.00040285176,0.0001623035,0.000108920474],"category_scores_gemma":[0.0020331352,0.00022159913,0.00031435944,0.00020456583,0.0005997783,0.00037823716,0.00019117584,0.0007603279,0.000016005273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013822751,0.0016944791,0.93169904,0.00002462944,0.00016326782,7.477105e-7,0.0011362509,0.000034916906,0.013900327,0.000027898352,0.00032958682,0.04960658],"study_design_scores_gemma":[0.014710972,0.0011587177,0.97960573,0.0007393698,0.000028780152,0.0000067552046,0.00076695083,0.0017912216,0.00068222464,0.000026247126,0.0002797786,0.00020323884],"about_ca_topic_score_codex":0.0005625975,"about_ca_topic_score_gemma":0.0006474264,"teacher_disagreement_score":0.04940334,"about_ca_system_score_codex":0.00016810023,"about_ca_system_score_gemma":0.00018756241,"threshold_uncertainty_score":0.9998321},"labels":[],"label_agreement":null},{"id":"W2760399652","doi":"10.1177/2055217317730096","title":"A comparison of multiple sclerosis disease activity after discontinuation of fingolimod and placebo","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Novartis Pharma; Novartis; Teva Pharmaceutical Industries; IC Design Education Center; Bayer HealthCare; Biogen","keywords":"Fingolimod; Discontinuation; Placebo; Medicine; Multiple sclerosis; Internal medicine; Clinical trial; Pathology; Psychiatry; Alternative medicine","score_opus":0.2742009206191111,"score_gpt":0.4397625722494697,"score_spread":0.16556165163035858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760399652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953783,0.002021533,0.00027677452,0.0013850003,0.00013667489,0.0005258747,0.00019022636,0.000011768258,0.000073849944],"genre_scores_gemma":[0.99632645,0.0012032443,0.0021347424,0.000028578783,0.00020743917,0.00004815621,0.000011680011,0.000025130068,0.00001456951],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99729663,0.00020319586,0.0010268625,0.00040985426,0.00076717907,0.00029627242],"domain_scores_gemma":[0.99737984,0.00092891906,0.0006248787,0.0003300361,0.00021599443,0.00052031316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007424245,0.00025864085,0.0008102233,0.00011620678,0.0005542097,0.00010471428,0.00016874533,0.00013210495,0.00010665988],"category_scores_gemma":[0.0010780136,0.00021637179,0.00037594416,0.000055845943,0.0011758411,0.0004846957,0.00015920779,0.0004410226,0.0000032993519],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009277829,0.002157262,0.87030584,0.000079904035,0.00025470855,0.000002702339,0.0007641106,0.000009857162,0.09632961,0.00001415482,0.000043412736,0.020760613],"study_design_scores_gemma":[0.011129673,0.0007237586,0.94970864,0.00072781416,0.00013831434,0.0000043851846,0.00039523293,0.009330597,0.027591137,0.000025733041,0.000040517287,0.00018419024],"about_ca_topic_score_codex":0.000072265946,"about_ca_topic_score_gemma":0.00006541624,"teacher_disagreement_score":0.07940281,"about_ca_system_score_codex":0.00003043082,"about_ca_system_score_gemma":0.000090310365,"threshold_uncertainty_score":0.8823386},"labels":[],"label_agreement":null},{"id":"W2761038804","doi":"10.1177/2055217317732802","title":"The efficacy of cladribine tablets in CIS patients retrospectively assigned the diagnosis of MS using modern criteria: Results from the ORACLE-MS study","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"EMD Serono; Merck KGaA","keywords":"Cladribine; Medicine; Oracle; Internal medicine; Computer science; Programming language","score_opus":0.25753686679645316,"score_gpt":0.43096976525358616,"score_spread":0.173432898457133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761038804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933844,0.0012127479,0.000055808137,0.0034312028,0.00030306433,0.0012430672,0.000306898,0.0000067532274,0.000056062752],"genre_scores_gemma":[0.9977714,0.0012108946,0.0005059222,0.000058997983,0.00035974395,0.00004367705,0.00001662112,0.000026384649,0.0000063507505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954583,0.00072927214,0.0017692859,0.0004496358,0.0012336181,0.00035987346],"domain_scores_gemma":[0.9924442,0.0054871724,0.00088113034,0.00061907637,0.0004003056,0.00016808658],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0024804785,0.00026688675,0.0006971896,0.000055916433,0.0016502489,0.00019434965,0.00060106715,0.00011989618,0.000044955726],"category_scores_gemma":[0.004154347,0.00013589888,0.00034845588,0.00013893729,0.0012626834,0.00028031456,0.00024862986,0.00073678885,0.0000010459885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072725355,0.0040332437,0.96304077,0.000005236895,0.0005105863,0.0000037458565,0.0037152923,0.00003490047,0.011565648,0.00000665545,0.00010875037,0.009702621],"study_design_scores_gemma":[0.022143772,0.0010879218,0.96685743,0.00036165037,0.00011582283,0.0000020217556,0.0014557752,0.0050375303,0.0026894377,0.000087425025,0.00003027272,0.00013093402],"about_ca_topic_score_codex":0.0014879489,"about_ca_topic_score_gemma":0.00045940233,"teacher_disagreement_score":0.014871236,"about_ca_system_score_codex":0.00008257484,"about_ca_system_score_gemma":0.00009695915,"threshold_uncertainty_score":0.99964947},"labels":[],"label_agreement":null},{"id":"W2769634427","doi":"10.1177/2055217317743097","title":"A double-blind, placebo-controlled, single ascending-dose study of remyelinating antibody rHIgM22 in people with multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"Acorda Therapeutics","keywords":"Tolerability; Placebo; Medicine; Pharmacodynamics; Pharmacokinetics; Multiple sclerosis; Adverse effect; Cohort; Internal medicine; Dosing; Biomarker; Pharmacology; Gastroenterology; Immunology; Pathology; Chemistry","score_opus":0.24974457371290776,"score_gpt":0.42491054057191163,"score_spread":0.17516596685900387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769634427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942766,0.00073578604,0.00010735322,0.00111389,0.00027060654,0.0031160444,0.00003149125,0.00003759043,0.0003106801],"genre_scores_gemma":[0.9960234,0.0005968189,0.0025334323,0.000046943955,0.00044605735,0.00021023025,0.000026163172,0.00007204467,0.000044907305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941639,0.0004314932,0.0021998063,0.0008669608,0.001610452,0.0007274269],"domain_scores_gemma":[0.9957994,0.0015967096,0.0010128766,0.00058939337,0.000431532,0.0005700673],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0023379326,0.00054835004,0.0017775404,0.00040979264,0.0013499199,0.00033409652,0.00046658173,0.00023471758,0.00011146099],"category_scores_gemma":[0.0010626101,0.0004175294,0.0004889083,0.00026603273,0.0006841203,0.0007263858,0.00023133565,0.0011477472,0.00000646501],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1082521,0.010316307,0.80212843,0.000050714723,0.0007348535,0.000031577136,0.0029595601,0.000105060295,0.07169231,0.000011252919,0.000013878574,0.0037039658],"study_design_scores_gemma":[0.26745105,0.0034692602,0.71595705,0.00089274585,0.0001665605,0.00004361552,0.0044921325,0.0041459072,0.0030357544,0.0000065284257,0.000012251935,0.000327174],"about_ca_topic_score_codex":0.00066497416,"about_ca_topic_score_gemma":0.0019274796,"teacher_disagreement_score":0.15919894,"about_ca_system_score_codex":0.00014655115,"about_ca_system_score_gemma":0.00018004078,"threshold_uncertainty_score":0.9999502},"labels":[],"label_agreement":null},{"id":"W2771252242","doi":"10.1177/2055217317745340","title":"Subcutaneous interferon β-1a three times weekly and the natural evolution of gadolinium-enhancing lesions into chronic black holes in relapsing and progressive multiple sclerosis: Analysis of PRISMS and SPECTRIMS trials","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Merck KGaA","keywords":"Multiple sclerosis; Placebo; Internal medicine; Medicine; Quartile; Gastroenterology; Lesion; Odds ratio; Pathology; Immunology; Confidence interval","score_opus":0.1445675270265466,"score_gpt":0.3956341391109991,"score_spread":0.25106661208445247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771252242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96325225,0.03322759,0.0005542101,0.0018234787,0.00012869974,0.00094582076,0.0000402105,0.000011316069,0.000016456914],"genre_scores_gemma":[0.98821294,0.009495666,0.0019904652,0.000020045263,0.00020942591,0.000027127893,0.000012399433,0.000023348264,0.000008579469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958562,0.0006225107,0.001956889,0.0005488958,0.00065962155,0.00035583184],"domain_scores_gemma":[0.9946999,0.0034793892,0.0010447438,0.00030153713,0.00022140141,0.00025305964],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.00323547,0.0003344582,0.0016525493,0.00037666486,0.00075058435,0.00017296687,0.00020177821,0.0002023539,0.000025710875],"category_scores_gemma":[0.0021784713,0.00022291609,0.00045533138,0.00021473136,0.0042922245,0.00038124082,0.00022689998,0.00076409464,4.4063776e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023730326,0.0011643022,0.57255125,0.00025637881,0.0039092735,0.000020992575,0.006806574,0.00011651861,0.3466075,0.00044964778,0.000019081222,0.044368174],"study_design_scores_gemma":[0.019211913,0.0015336842,0.91864216,0.0020148088,0.00097154913,0.00005019953,0.0028339678,0.047525078,0.006565611,0.00041006602,0.0000029130267,0.0002380283],"about_ca_topic_score_codex":0.00032484002,"about_ca_topic_score_gemma":0.00096475816,"teacher_disagreement_score":0.34609094,"about_ca_system_score_codex":0.00012273976,"about_ca_system_score_gemma":0.00013910519,"threshold_uncertainty_score":0.9984175},"labels":[],"label_agreement":null},{"id":"W2779004527","doi":"10.1177/2055217317747625","title":"Environmental temperature and exercise modality independently impact central and muscle fatigue among people with multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Agencia Estatal de Investigación","keywords":"Multiple sclerosis; Modality (human–computer interaction); Physical medicine and rehabilitation; Muscle fatigue; Psychology; Physical therapy; Medicine; Psychiatry; Computer science; Electromyography; Artificial intelligence","score_opus":0.10784482978458117,"score_gpt":0.35341353616226173,"score_spread":0.24556870637768058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2779004527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942092,0.0029112427,0.000063792395,0.0013585292,0.00014469762,0.00094848,0.00028462466,0.00003500803,0.000044437493],"genre_scores_gemma":[0.98962504,0.008394227,0.0013512961,0.000085012856,0.00034368061,0.000056642224,0.000054862132,0.00006022238,0.000029011604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962225,0.00020279546,0.0009046204,0.00086258794,0.0010642621,0.000743265],"domain_scores_gemma":[0.9973356,0.00045857622,0.00037644187,0.00043197518,0.00008800291,0.0013094035],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0007242386,0.0005607763,0.00094831473,0.00012323172,0.002111818,0.0006487551,0.00024262453,0.0002818514,0.00015551185],"category_scores_gemma":[0.0002345126,0.00041154117,0.00034620482,0.00007092103,0.0016076096,0.0010302853,0.00024438807,0.0011018126,0.000002567065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002090992,0.001081999,0.94714594,0.000045826313,0.0003933334,0.000022985761,0.0011617579,0.000032258216,0.037068646,0.00000499849,0.00005097398,0.010900267],"study_design_scores_gemma":[0.015394557,0.0008856809,0.974491,0.0005945075,0.00016843472,0.00011575972,0.001228014,0.0035995066,0.0030277558,0.000027560467,0.000018432358,0.00044881878],"about_ca_topic_score_codex":0.00042546747,"about_ca_topic_score_gemma":0.00030965917,"teacher_disagreement_score":0.03404089,"about_ca_system_score_codex":0.00011439356,"about_ca_system_score_gemma":0.00009593763,"threshold_uncertainty_score":0.99983364},"labels":[],"label_agreement":null},{"id":"W2791060017","doi":"10.1177/2055217318761168","title":"Prolonged-Release Fampridine as Adjunct Therapy to Active Motor Training in MS Patients: A Pilot, Double-Blind, Randomized, Placebo-Controlled Study","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Clinique Neuro-Outaouais","funders":"Sanofi Genzyme; Biogen; Teva Pharmaceutical Industries; American Academy of Neurology","keywords":"Placebo; Medicine; Randomized controlled trial; Statistical significance; Physical therapy; Rehabilitation; Clinical trial; Surgery; Internal medicine","score_opus":0.2179546519039415,"score_gpt":0.41506609884793993,"score_spread":0.19711144694399843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791060017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865518,0.00055404654,0.00009131064,0.0019822575,0.0004064018,0.009985922,0.000034310815,0.00004008151,0.000353819],"genre_scores_gemma":[0.9954283,0.0005714951,0.0006744486,0.0006706761,0.0011186822,0.0013717035,0.000024961357,0.000060007453,0.00007971102],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99408793,0.0010398848,0.0019783864,0.00081688754,0.0013919867,0.0006849391],"domain_scores_gemma":[0.9958183,0.0021850774,0.00034164713,0.0002504934,0.00053773314,0.00086673454],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030054012,0.0005294901,0.0019228656,0.00043956586,0.0005488996,0.00014027308,0.00024184168,0.00016065192,0.000466765],"category_scores_gemma":[0.0015409443,0.00037352744,0.00063848094,0.00036256463,0.0006315013,0.00037742633,0.00009395744,0.000945867,0.000050358478],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91258526,0.008585697,0.043844618,0.000006621629,0.00122246,0.0000145024915,0.0103495745,0.00001004632,0.008773221,0.000013452684,0.00005539467,0.014539155],"study_design_scores_gemma":[0.7702801,0.011784306,0.21083719,0.00020966941,0.00011006488,0.000012234262,0.0036784087,0.0009206853,0.0017263766,0.000034868954,0.00008345477,0.0003226174],"about_ca_topic_score_codex":0.00018124905,"about_ca_topic_score_gemma":0.00024660482,"teacher_disagreement_score":0.16699257,"about_ca_system_score_codex":0.0001508323,"about_ca_system_score_gemma":0.0002752592,"threshold_uncertainty_score":0.9998717},"labels":[],"label_agreement":null},{"id":"W2791535469","doi":"10.1177/2055217318760642","title":"No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University; NeuroRx Research (Canada); Research Canada","funders":"Roche","keywords":"Ocrelizumab; Medicine; Multiple sclerosis; Internal medicine; Interferon beta-1a; Gastroenterology; Interferon beta; Immunology","score_opus":0.12229452787253223,"score_gpt":0.358712952255066,"score_spread":0.23641842438253377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791535469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966195,0.000940032,0.0006726568,0.00061883085,0.000077400095,0.0008264143,0.0001575429,0.00003242956,0.00005515181],"genre_scores_gemma":[0.99631834,0.0007980046,0.00240539,0.0001055784,0.00016123147,0.00004831686,0.00007628186,0.00005203987,0.000034826993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952561,0.00048470046,0.0012834407,0.00085478014,0.0015279147,0.0005930348],"domain_scores_gemma":[0.99633855,0.0012612579,0.00048856734,0.00038744826,0.00074802386,0.0007761409],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00079442066,0.00049615675,0.0012183071,0.00040764167,0.0004402128,0.00010332203,0.00023060628,0.0001754906,0.00028148908],"category_scores_gemma":[0.00037066272,0.00035186505,0.00045533598,0.0008546864,0.0013075793,0.00074310234,0.00009785921,0.0007413439,0.000009744153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.117792584,0.0034130337,0.8552099,0.000049583537,0.0013874604,0.000005033403,0.0002860081,0.00003476955,0.01929871,0.0000016388228,0.00008947968,0.0024317978],"study_design_scores_gemma":[0.019041743,0.014469537,0.9522866,0.0021325082,0.00065478776,0.000002487144,0.00013293372,0.0049103196,0.0059640226,0.0000022139632,0.000024213097,0.000378643],"about_ca_topic_score_codex":0.00023506394,"about_ca_topic_score_gemma":0.000184867,"teacher_disagreement_score":0.098750845,"about_ca_system_score_codex":0.00020152605,"about_ca_system_score_gemma":0.00016100447,"threshold_uncertainty_score":0.9998933},"labels":[],"label_agreement":null},{"id":"W2792025795","doi":"10.1177/2055217318754368","title":"National estimates of self-reported sitting time in adults with multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Multiple Sclerosis Society","keywords":"Sitting; Medicine; Underweight; Physical therapy; Demography; Population; Multiple sclerosis; Pediatrics; Internal medicine; Body mass index; Psychiatry; Environmental health","score_opus":0.1379962288639107,"score_gpt":0.3734471099918637,"score_spread":0.235450881127953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792025795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99692684,0.00066512835,0.00016644991,0.000896413,0.00011168307,0.0006584579,0.000060370323,0.000061350656,0.0004533158],"genre_scores_gemma":[0.9718374,0.0005109829,0.026847309,0.00014300057,0.0005083679,0.000040162755,0.000049633614,0.000045492015,0.000017677536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955879,0.0001908486,0.0016771914,0.00060389464,0.0014281323,0.0005120394],"domain_scores_gemma":[0.9964908,0.0016157755,0.0004468166,0.00018893709,0.0008265468,0.00043115948],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013914553,0.0003657129,0.00081135245,0.00030367312,0.00039377777,0.00006449988,0.0001699452,0.00019872109,0.00033637753],"category_scores_gemma":[0.0010554683,0.00028658923,0.00028974973,0.00041787224,0.0008892749,0.00038715132,0.000084772735,0.0006083265,0.000025958909],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00562982,0.0031146242,0.89243424,0.00007581591,0.0008706882,0.000017745157,0.00210669,0.000037965066,0.090237826,0.00002562665,0.00019275608,0.00525621],"study_design_scores_gemma":[0.018202772,0.001853441,0.9277939,0.0016410941,0.000096232776,0.00011505064,0.0006656553,0.031036425,0.01817885,0.00005183393,0.0000582854,0.00030643778],"about_ca_topic_score_codex":0.000075467564,"about_ca_topic_score_gemma":0.00007644704,"teacher_disagreement_score":0.072058976,"about_ca_system_score_codex":0.00012168109,"about_ca_system_score_gemma":0.0002815437,"threshold_uncertainty_score":0.99995863},"labels":[],"label_agreement":null},{"id":"W2804123946","doi":"10.1177/2055217318778610","title":"Relapse Rate and MRI Activity in Young Adult Patients With Multiple Sclerosis: A Post Hoc Analysis of Phase 3 Fingolimod Trials","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Fingolimod; Post-hoc analysis; Multiple sclerosis; Post hoc; Medicine; Internal medicine; Oncology; Psychiatry","score_opus":0.15633756185160314,"score_gpt":0.4018421928346263,"score_spread":0.24550463098302316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804123946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965932,0.0006039392,0.0002704533,0.0009055239,0.0001421339,0.00096437574,0.00045826656,0.000023117987,0.00003902675],"genre_scores_gemma":[0.99511045,0.0017800187,0.0025102564,0.00015790085,0.0002492769,0.000055169236,0.00008947858,0.000038355436,0.000009073365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99497616,0.000937647,0.0018632633,0.0007282477,0.0009732273,0.0005214714],"domain_scores_gemma":[0.9952876,0.002387036,0.00065224327,0.00027794184,0.00083437137,0.00056079734],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025655455,0.0004265093,0.0017650297,0.0006281692,0.00042025986,0.00010235469,0.00015499824,0.00022778666,0.00015236253],"category_scores_gemma":[0.0019028856,0.00031362957,0.0005713442,0.0007905372,0.0010780019,0.0005019499,0.00009549819,0.0006623452,0.0000033835672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029819308,0.0054016835,0.87889975,0.00003536355,0.0025561913,0.000004934825,0.0017208385,0.000023422286,0.07029275,0.000012346266,0.000033585387,0.011199835],"study_design_scores_gemma":[0.05093433,0.004664771,0.92368567,0.0005287643,0.00083124643,0.000005767726,0.0006419365,0.012288191,0.006098098,0.000007640956,0.000011815096,0.0003017854],"about_ca_topic_score_codex":0.00033271205,"about_ca_topic_score_gemma":0.0012328345,"teacher_disagreement_score":0.06419465,"about_ca_system_score_codex":0.000092104914,"about_ca_system_score_gemma":0.0001276541,"threshold_uncertainty_score":0.9999316},"labels":[],"label_agreement":null},{"id":"W2805018524","doi":"10.1177/2055217318775236","title":"Clinical efficacy of teriflunomide over a fixed 2-year duration in the TOWER study","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"F. Hoffmann-La Roche; Sanofi","keywords":"Teriflunomide; Medicine; Context (archaeology); Multiple sclerosis; Clinical trial; Internal medicine; Physical therapy; Fingolimod; Immunology","score_opus":0.2095206560608331,"score_gpt":0.44714544103646325,"score_spread":0.23762478497563017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805018524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99663645,0.00027660906,0.00006279751,0.0014545328,0.00029363148,0.00097622315,0.000016521875,0.000012883696,0.00027035488],"genre_scores_gemma":[0.9967148,0.00036565316,0.0014735981,0.00032691404,0.0010453436,0.000023793586,0.000010517933,0.000019272353,0.000020157055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956992,0.00076149346,0.0019176935,0.00042136112,0.0008924514,0.00030778593],"domain_scores_gemma":[0.9971161,0.0019359402,0.00027824024,0.0002620847,0.00018397892,0.00022369197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003183996,0.00022219006,0.00062238285,0.00012894682,0.00028332052,0.00006998272,0.00021667019,0.00014349533,0.00039098383],"category_scores_gemma":[0.0009920626,0.00014433038,0.00039420603,0.00023930814,0.000824193,0.00021299254,0.0000696155,0.00071367744,0.0000119101305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003964162,0.005938927,0.96939564,0.0000068992763,0.00021239802,0.00000968951,0.002551458,0.0000013541617,0.011745354,0.000027427275,0.00037973793,0.0057669617],"study_design_scores_gemma":[0.019053698,0.0034479569,0.97292495,0.00014147663,0.00006879363,0.00002038461,0.0028486657,0.0005423758,0.000488593,0.000023287852,0.00030179534,0.00013803679],"about_ca_topic_score_codex":0.000047892358,"about_ca_topic_score_gemma":0.00008094364,"teacher_disagreement_score":0.015089534,"about_ca_system_score_codex":0.000036033536,"about_ca_system_score_gemma":0.000101731894,"threshold_uncertainty_score":0.5885622},"labels":[],"label_agreement":null},{"id":"W2889134371","doi":"10.1177/2055217318796684","title":"Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Deutsche Forschungsgemeinschaft","keywords":"Neuromyelitis optica; Medicine; Myelin oligodendrocyte glycoprotein; Multiple sclerosis; Neuropathic pain; Immunoglobulin G; Immunology; Internal medicine; Antibody; Anesthesia; Experimental autoimmune encephalomyelitis","score_opus":0.07959922474329705,"score_gpt":0.36002917611595747,"score_spread":0.2804299513726604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889134371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798321,0.002053392,0.0007516811,0.015347393,0.0002488386,0.0007799827,0.00010247272,0.00003571035,0.00084840273],"genre_scores_gemma":[0.99120575,0.004016735,0.0030690746,0.0007081653,0.00084385346,0.0000374374,0.000034879286,0.000045254597,0.00003885004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99601984,0.000661217,0.0010934896,0.00071127224,0.0007580683,0.00075608346],"domain_scores_gemma":[0.99695283,0.0018373323,0.00016203929,0.00017425678,0.00012629565,0.00074723014],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016674827,0.00039922725,0.0007247818,0.00022918041,0.0005844894,0.00014099194,0.00014097767,0.00019947639,0.00026658364],"category_scores_gemma":[0.000648296,0.00033638623,0.00030267762,0.00025897406,0.0014263991,0.0003567232,0.000119371696,0.00090672367,0.000017781782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005508581,0.003435918,0.82733613,0.00005361042,0.0007715257,0.00009653282,0.004155969,0.000013161812,0.036902715,0.0006806831,0.00036662878,0.12067855],"study_design_scores_gemma":[0.009722374,0.003537715,0.97514224,0.00048780435,0.00005422093,0.00009685339,0.000964619,0.0059300237,0.0027802056,0.00051294075,0.0004187643,0.00035223886],"about_ca_topic_score_codex":0.00016512744,"about_ca_topic_score_gemma":0.00031960406,"teacher_disagreement_score":0.14780611,"about_ca_system_score_codex":0.00011242283,"about_ca_system_score_gemma":0.000115079405,"threshold_uncertainty_score":0.9999088},"labels":[],"label_agreement":null},{"id":"W2910743644","doi":"10.1177/2055217318824612","title":"Advanced imaging findings in progressive solitary sclerosis: a single lesion or a global disease?","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Genentech; Biogen","keywords":"Multiple sclerosis; White matter; Myelin; Pathology; Medicine; Lesion; Creatine; Corticospinal tract; Abnormality; Demyelinating disease; Magnetic resonance imaging; Internal medicine; Central nervous system; Radiology; Diffusion MRI; Immunology","score_opus":0.1647653451747893,"score_gpt":0.403542478242856,"score_spread":0.2387771330680667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910743644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869219,0.007613744,0.00006122919,0.003680572,0.00032523976,0.0011001951,0.00008105233,0.000051413557,0.00016464201],"genre_scores_gemma":[0.9940219,0.0013042195,0.0036426096,0.0005449076,0.00028609805,0.00007430604,0.000040731546,0.00003778687,0.000047459722],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961456,0.00024096841,0.0011982598,0.0007211149,0.0010253602,0.00066871586],"domain_scores_gemma":[0.99808115,0.00057712424,0.00017736552,0.00022408713,0.0001712394,0.00076905626],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006724717,0.0003819212,0.00071902195,0.00015922484,0.00031460158,0.000135301,0.00019077044,0.00012533426,0.00046802222],"category_scores_gemma":[0.0004351356,0.0002906795,0.00041298792,0.00033131396,0.0004135873,0.0006221276,0.00013651616,0.00065752136,0.000040022012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0092703765,0.0026870526,0.9090879,0.00007247593,0.00015008416,0.000092840244,0.00041809364,0.000040907682,0.049974706,0.000039316303,0.00014097177,0.028025297],"study_design_scores_gemma":[0.016851645,0.00090027484,0.9723692,0.002107658,0.000053720687,0.000091477115,0.0014755969,0.00418397,0.0013351792,0.00010737353,0.000182527,0.0003414037],"about_ca_topic_score_codex":0.000023178492,"about_ca_topic_score_gemma":0.000024708708,"teacher_disagreement_score":0.0632813,"about_ca_system_score_codex":0.0002812611,"about_ca_system_score_gemma":0.00023481264,"threshold_uncertainty_score":0.9999545},"labels":[],"label_agreement":null},{"id":"W2912932573","doi":"10.1177/2055217318823796","title":"Effect of different doses of gadolinium contrast agent on clinical outcomes in MS","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Lanthanide and Transition Metal Complexes","field":"Materials Science","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Statistics Canada; Ottawa Hospital; University of British Columbia","funders":"University of British Columbia; Acorda Therapeutics; Biogen","keywords":"Medicine; Cohort; Expanded Disability Status Scale; Demographics; Hazard ratio; Internal medicine; Adverse effect; Multiple sclerosis; Cohort study; Confidence interval; Demography; Psychiatry","score_opus":0.10232360738687998,"score_gpt":0.37066658720186113,"score_spread":0.2683429798149811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912932573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998245,0.00024409361,0.000056768287,0.00015085869,0.00080817693,0.00031822058,0.000082400664,0.000009310215,0.00008514857],"genre_scores_gemma":[0.99931026,0.00019026552,0.00026100795,0.00009683278,0.00010331384,0.000006410121,0.000009953601,0.000012678987,0.000009285165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965861,0.0007586837,0.001644698,0.00030854414,0.00049620727,0.00020579086],"domain_scores_gemma":[0.99645674,0.0028638165,0.0003343739,0.00013795559,0.000047217934,0.00015989097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015495644,0.00021099357,0.0009006848,0.000070139766,0.000060519727,0.00003083488,0.00017179857,0.00012253433,0.0006952205],"category_scores_gemma":[0.00009368192,0.00013690974,0.0005098644,0.000059272774,0.00027144485,0.0001511538,0.000025689493,0.00030019498,0.000025705762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024484755,0.0014178075,0.6797532,0.000028818136,0.0000651641,0.0000025260936,0.000107050255,0.000037503854,0.31502324,0.00028311176,0.0000053841673,0.00082771166],"study_design_scores_gemma":[0.008107865,0.0034891556,0.7443074,0.00018334869,0.0000357421,0.000006054259,0.00006300352,0.0001789162,0.24333689,0.00014724082,0.000008434403,0.00013594532],"about_ca_topic_score_codex":0.000024275312,"about_ca_topic_score_gemma":0.000015031166,"teacher_disagreement_score":0.07168637,"about_ca_system_score_codex":0.000012611676,"about_ca_system_score_gemma":0.000024200506,"threshold_uncertainty_score":0.7612177},"labels":[],"label_agreement":null},{"id":"W2920925212","doi":"10.1177/2055217319835226","title":"Does attendance at the ECTRIMS congress impact on therapeutic decisions in multiple sclerosis care?","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Sanofi Genzyme; Genentech; Multiple Sclerosis International Federation; Teva Pharmaceutical Industries","keywords":"Attendance; Medicine; Multiple sclerosis; Tolerability; Health care; Family medicine; Adverse effect; Psychiatry; Internal medicine","score_opus":0.4829953275870632,"score_gpt":0.4583553363929038,"score_spread":0.024639991194159383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920925212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97884804,0.007159378,0.00013916714,0.010891879,0.0015091883,0.0007998066,0.0004342496,0.000018856834,0.0001994543],"genre_scores_gemma":[0.9942967,0.0011795261,0.00040656162,0.0034892077,0.00035949948,0.00005582088,0.000037136648,0.000039271297,0.00013627435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99437726,0.00063366164,0.003555317,0.0006774266,0.00027990912,0.00047643032],"domain_scores_gemma":[0.99147266,0.0067103854,0.001074345,0.00037831755,0.00006496953,0.0002993262],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00560979,0.00032048064,0.00093797833,0.00019301631,0.00059541134,0.0001888522,0.00035391198,0.00021695778,0.0009932795],"category_scores_gemma":[0.00062518386,0.00021180701,0.00050927995,0.00016859536,0.0002483801,0.0004586372,0.00005621196,0.0005919562,0.0006795523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056080637,0.0004629726,0.9915766,0.000013842499,0.00014358209,9.68825e-7,0.0018953687,0.0011596694,0.00052306853,0.0011945469,0.0004888046,0.0019797564],"study_design_scores_gemma":[0.0061434368,0.00037781885,0.98032063,0.00027372775,0.000010055276,0.0000092464625,0.0020789295,0.006707446,0.00028996455,0.0012360098,0.0021831733,0.00036958128],"about_ca_topic_score_codex":0.0002917243,"about_ca_topic_score_gemma":0.00041575264,"teacher_disagreement_score":0.015448682,"about_ca_system_score_codex":0.0005035527,"about_ca_system_score_gemma":0.000103869206,"threshold_uncertainty_score":0.99991995},"labels":[],"label_agreement":null},{"id":"W2922820066","doi":"10.1177/2055217319836664","title":"Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"National Institute of Neurological Disorders and Stroke; European Regional Development Fund; Chugai Pharmaceutical; Novartis Pharmaceuticals UK Limited; Georgia Clinical and Translational Science Alliance; Türk Nöroloji Derneği; Servier; National Institutes of Health; National Institute of Allergy and Infectious Diseases; Türkiye Bilimsel ve Teknolojik Araştırma Kurumu; National Multiple Sclerosis Society; Genentech; Multiple Sclerosis Society; Action Medical Research; Novartis Pharma; Generalitat de Catalunya; EMD Serono; Zogenix; Mayo Foundation for Medical Education and Research; Alexion Pharmaceuticals; National Center for Advancing Translational Sciences; Teva Pharmaceutical Industries; Biogen; Pfizer; Race to Erase MS; Acorda Therapeutics; Sanofi","keywords":"Magnetic resonance imaging; Medicine; Multiple sclerosis; Cerebrospinal fluid; Clinically isolated syndrome; Confidence interval; Prospective cohort study; McDonald criteria; Radiology; Pathology; Internal medicine; Immunology","score_opus":0.09120027534748268,"score_gpt":0.33570227344725173,"score_spread":0.24450199809976905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922820066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99427587,0.00093887164,0.00019857378,0.0024679762,0.00015853088,0.0016245301,0.00019549945,0.00003294919,0.0001072159],"genre_scores_gemma":[0.9945046,0.0014765833,0.003202252,0.00037722528,0.00023501596,0.00006366013,0.000061162755,0.00004147643,0.000038052127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956331,0.0005041378,0.0014881353,0.00069486164,0.0010803642,0.0005994046],"domain_scores_gemma":[0.9972534,0.00126777,0.000262721,0.0003514402,0.00023999448,0.00062467146],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015128739,0.00042276346,0.0010414333,0.00023620544,0.00029875658,0.00009246187,0.0003590226,0.00022563865,0.0006298477],"category_scores_gemma":[0.0003405786,0.00026243975,0.0003836122,0.0004630176,0.0006336097,0.00026630357,0.0001522122,0.00096616324,0.000024449051],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074853115,0.001588445,0.93594426,0.000019401725,0.00052853726,0.000012637672,0.00039941908,0.00014641513,0.052254368,0.000015447504,0.0002825942,0.0013231621],"study_design_scores_gemma":[0.013824422,0.003688338,0.975692,0.00057900127,0.00007195925,0.00037859957,0.0003851422,0.0032758608,0.0016899199,0.000015137137,0.00010237713,0.000297283],"about_ca_topic_score_codex":0.00016466578,"about_ca_topic_score_gemma":0.00005003453,"teacher_disagreement_score":0.05056445,"about_ca_system_score_codex":0.0000977189,"about_ca_system_score_gemma":0.00013988295,"threshold_uncertainty_score":0.9999828},"labels":[],"label_agreement":null},{"id":"W2942919250","doi":"10.1177/2055217319844796","title":"Multicentre assessment of motor and sensory evoked potentials in multiple sclerosis: reliability and implications for clinical trials","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Clinique Neuro-Outaouais","funders":"Schweizerische Multiple Sklerose Gesellschaft; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Bayer HealthCare; Biogen","keywords":"Multiple sclerosis; Audiology; Remyelination; Medicine; Clinical trial; Psychology; Physical medicine and rehabilitation; Analysis of variance; Internal medicine; Physical therapy; Central nervous system","score_opus":0.4143189573992716,"score_gpt":0.49663277993960214,"score_spread":0.08231382254033054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942919250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98804814,0.0033852654,0.00046848957,0.0041031735,0.0003001149,0.0032022772,0.00043419856,0.00002391465,0.00003440412],"genre_scores_gemma":[0.97058403,0.011014644,0.017645534,0.00018664302,0.0003043047,0.00014546825,0.000044726396,0.00003849955,0.000036144087],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9931681,0.0014160187,0.0034800079,0.0008766706,0.0005804605,0.00047870708],"domain_scores_gemma":[0.98654956,0.011400336,0.0006924272,0.00033342652,0.00040041952,0.0006238076],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008586025,0.0003697086,0.0018057219,0.00020761645,0.0003094565,0.000088708395,0.0001455102,0.00034213954,0.00008307103],"category_scores_gemma":[0.0045911493,0.00029860984,0.00068093,0.00014946275,0.00075566076,0.0003201715,0.00012961446,0.00074496545,0.0000020875823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002707153,0.0020257111,0.8299235,0.00013309986,0.0003394611,7.9938894e-7,0.00024203493,0.00001956484,0.14965387,0.000070884664,0.00006163287,0.014822294],"study_design_scores_gemma":[0.029110918,0.001206325,0.9508468,0.0005144948,0.00017879927,0.000016175254,0.00094076415,0.015418753,0.0012048136,0.00014849617,0.00015078325,0.00026291172],"about_ca_topic_score_codex":0.000053541942,"about_ca_topic_score_gemma":0.000035193545,"teacher_disagreement_score":0.14844905,"about_ca_system_score_codex":0.00008191968,"about_ca_system_score_gemma":0.00019149094,"threshold_uncertainty_score":0.9999466},"labels":[],"label_agreement":null},{"id":"W2971369168","doi":"10.1177/2055217319871582","title":"Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis; a longitudinal OCT study","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Instituto de Salud Carlos III; Sanofi Genzyme; Chugai Pharmaceutical; Novartis Pharma; Ipsen; Moorfields Eye Hospital NHS Foundation Trust; Deutsche Forschungsgemeinschaft; Sanofi; Bayer HealthCare; Genentech; Multiple Sclerosis Society; Alexion Pharmaceuticals; Merz Pharmaceuticals; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; Teva Pharmaceutical Industries; Celgene; Biogen; University College London; Allergan; Arthur Arnstein Stiftung","keywords":"Multiple sclerosis; Medicine; Optic neuritis; Retinal; Inner nuclear layer; Inner plexiform layer; Ophthalmology; Internal medicine; Neurodegeneration; Disease; Pathology; Immunology","score_opus":0.20663405230788706,"score_gpt":0.3833640099548292,"score_spread":0.17672995764694216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971369168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946586,0.00083422783,0.000025039677,0.0019003334,0.00041313603,0.0018599541,0.000055252087,0.00007757887,0.0001759111],"genre_scores_gemma":[0.9974676,0.0006081145,0.0007700278,0.00024362741,0.0005858725,0.00008808627,0.00002056786,0.00009188799,0.00012425832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940336,0.00079099677,0.0015368933,0.001118617,0.0016505935,0.000869297],"domain_scores_gemma":[0.99687743,0.00090763083,0.0003372595,0.00048246462,0.0002686236,0.0011265815],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018635899,0.0005898906,0.0011058359,0.0003746121,0.0005922895,0.0002160509,0.00031219865,0.0002494082,0.00084289094],"category_scores_gemma":[0.0006484783,0.0005098876,0.00059785816,0.0004044564,0.0005345818,0.00076357136,0.00025184697,0.0017355178,0.00017868851],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011546326,0.0058766217,0.9129221,0.00006426679,0.00034190045,0.00010780952,0.0009346138,0.000068765985,0.06436145,0.000017290966,0.00019939171,0.0035594464],"study_design_scores_gemma":[0.021899711,0.0021201768,0.9647184,0.00061905483,0.000103102095,0.00003506225,0.001308488,0.007803971,0.0005557106,0.000020905685,0.00030719856,0.0005081957],"about_ca_topic_score_codex":0.00012982237,"about_ca_topic_score_gemma":0.00018512954,"teacher_disagreement_score":0.063805744,"about_ca_system_score_codex":0.00026173872,"about_ca_system_score_gemma":0.00024868207,"threshold_uncertainty_score":0.9997353},"labels":[],"label_agreement":null},{"id":"W2976176272","doi":"10.1177/2055217319869360","title":"Cannabis-based product use in a multiple sclerosis cohort","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Demographics; Cohort; Cannabis; Multiple sclerosis; Medical record; Disease; Retrospective cohort study; Internal medicine; Family medicine; Psychiatry; Demography","score_opus":0.1555334950228032,"score_gpt":0.3546816758158016,"score_spread":0.19914818079299842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2976176272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98894614,0.0012951302,0.000047619014,0.0078504095,0.00041108226,0.0012234144,0.000058033464,0.00003379522,0.00013436934],"genre_scores_gemma":[0.9961588,0.00030351066,0.0012665747,0.0007559275,0.00036729316,0.00008605979,0.000063261316,0.000052349784,0.00094623334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963205,0.0002539443,0.0011736966,0.00070934143,0.0009766226,0.0005659158],"domain_scores_gemma":[0.9984347,0.00024007737,0.00016449016,0.0003083418,0.00022431825,0.000628037],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011548897,0.00032573382,0.0006851742,0.00033618964,0.00026299895,0.00018312827,0.00016124744,0.00019962344,0.000730884],"category_scores_gemma":[0.00037108664,0.00027408218,0.0004716059,0.0004043259,0.00033335545,0.00040597245,0.000046030942,0.00095283013,0.00004638361],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024778082,0.0018072563,0.9432401,0.00004046773,0.00010988564,0.000022570905,0.00014136983,0.00013271856,0.047285955,0.000037846385,0.0016030003,0.0031010194],"study_design_scores_gemma":[0.013723122,0.00080788636,0.96586484,0.00039638704,0.000045909834,0.00007227527,0.00020414019,0.0056143967,0.008986435,0.000014493598,0.0039532394,0.00031690582],"about_ca_topic_score_codex":0.00037098303,"about_ca_topic_score_gemma":0.00028727544,"teacher_disagreement_score":0.03829952,"about_ca_system_score_codex":0.00015608322,"about_ca_system_score_gemma":0.00039709368,"threshold_uncertainty_score":0.99997115},"labels":[],"label_agreement":null},{"id":"W2980707925","doi":"10.1177/2055217319879952","title":"Magnetic resonance spectroscopy evidence for declining gliosis in MS patients treated with ocrelizumab versus interferon beta-1a","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; Chugai Pharmaceutical; Multiple Sclerosis Society of Canada; Acorda Therapeutics; EMD Serono; Vancouver Coastal Health Research Institute; Michael Smith Health Research BC; Vertex Pharmaceuticals; Multiple Sclerosis Society; Sanofi Genzyme; F. Hoffmann-La Roche; Teva Pharmaceutical Industries; Biogen; Celgene; Sanofi","keywords":"Ocrelizumab; Gliosis; Medicine; Interferon beta; Magnetic resonance imaging; Multiple sclerosis; Internal medicine; Oncology; Nuclear magnetic resonance; Immunology; Pathology; Radiology; Physics","score_opus":0.20204028880489555,"score_gpt":0.4063018138214152,"score_spread":0.20426152501651967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980707925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915432,0.00572459,0.00008454716,0.0008715726,0.0002602577,0.0013040989,0.000043373897,0.00002682362,0.00014157392],"genre_scores_gemma":[0.9906788,0.0022792043,0.0064544417,0.0001307141,0.00023534526,0.00010281623,0.00003239649,0.00004543228,0.000040858817],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996677,0.00019617345,0.0011243721,0.00066341704,0.00079131935,0.0005477564],"domain_scores_gemma":[0.99660164,0.0023798672,0.00019703375,0.00021508148,0.00025289058,0.00035346768],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00067994907,0.0003443261,0.0007364871,0.00018601702,0.00023373721,0.00009692538,0.00017709535,0.00015814354,0.0002910548],"category_scores_gemma":[0.0004052633,0.00026334336,0.00030209095,0.00024766818,0.00030212462,0.00039792465,0.000058484246,0.0006227559,0.00001956979],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049319077,0.0011903793,0.92559814,0.000040839233,0.00013578468,0.0000054562265,0.0003458619,0.000014023868,0.013834631,0.000014903116,0.00008896074,0.009411952],"study_design_scores_gemma":[0.041390285,0.014405209,0.9336239,0.0015803904,0.00007913717,0.000009659603,0.00031346042,0.002525766,0.0055115023,0.000008940849,0.0002635375,0.0002882268],"about_ca_topic_score_codex":0.000055120374,"about_ca_topic_score_gemma":0.00008034052,"teacher_disagreement_score":0.013214829,"about_ca_system_score_codex":0.00018910164,"about_ca_system_score_gemma":0.00011325603,"threshold_uncertainty_score":0.9999819},"labels":[],"label_agreement":null},{"id":"W2984612893","doi":"10.1177/2055217319885983","title":"Machine learning in secondary progressive multiple sclerosis: an improved predictive model for short-term disability progression","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; University of British Columbia","funders":"Multiple Sclerosis Society of Canada","keywords":"Expanded Disability Status Scale; Logistic regression; Multiple sclerosis; Machine learning; Medicine; Receiver operating characteristic; Support vector machine; Clinical trial; Physical therapy; Artificial intelligence; Internal medicine; Computer science","score_opus":0.1566684101755616,"score_gpt":0.4037198011592445,"score_spread":0.2470513909836829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984612893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907669,0.0029118678,0.0014761083,0.0008190186,0.00023614021,0.0033688543,0.00027691235,0.00009289799,0.000051343817],"genre_scores_gemma":[0.98804665,0.00078973564,0.009767495,0.000109978486,0.0003954525,0.00047535182,0.00028953637,0.00007824517,0.000047545913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953225,0.00042334376,0.0015813784,0.0010513428,0.0008635245,0.00075789256],"domain_scores_gemma":[0.9972682,0.0011054218,0.000286631,0.00030723814,0.00029915918,0.0007333768],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016283813,0.00050614186,0.0010005935,0.0001499999,0.0005563876,0.00015340757,0.00024533883,0.0003403254,0.00016526501],"category_scores_gemma":[0.0005073346,0.00040482124,0.0005449382,0.00018321679,0.0006963296,0.00084512273,0.00014548781,0.001574301,0.0000045421375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009266494,0.003986627,0.8123025,0.000119928874,0.00024804386,0.0000041750704,0.0013876207,0.00048736867,0.08768028,0.000009388551,0.000010071544,0.08449752],"study_design_scores_gemma":[0.012311687,0.0022751978,0.5345078,0.0005094256,0.00004700656,0.000017025895,0.00062655006,0.44713724,0.0022497477,0.0000322131,0.000022002,0.00026407366],"about_ca_topic_score_codex":0.000022936076,"about_ca_topic_score_gemma":0.00007542526,"teacher_disagreement_score":0.44664988,"about_ca_system_score_codex":0.00021707227,"about_ca_system_score_gemma":0.0002334337,"threshold_uncertainty_score":0.9998404},"labels":[],"label_agreement":null},{"id":"W2993353083","doi":"10.1177/2055217319887191","title":"Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing–remitting multiple sclerosis in a real-world clinical setting: PROTEC","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; McGill University; Montreal Neurological Institute and Hospital","funders":"Biogen","keywords":"Dimethyl fumarate; Medicine; Multiple sclerosis; Relapsing remitting; Internal medicine; Clinical trial; Observational study; Physical therapy; Disease; Immunology","score_opus":0.11693464970568275,"score_gpt":0.3796222440385658,"score_spread":0.2626875943328831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993353083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99594885,0.0003720456,0.000028394885,0.00028605398,0.00034798365,0.0028361431,0.00005617319,0.000036128426,0.00008824015],"genre_scores_gemma":[0.9963204,0.00085218134,0.0023775299,0.00012881038,0.000098761324,0.0000867481,0.000048163263,0.00007470295,0.000012691402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.990621,0.0020179765,0.003978686,0.0011765915,0.0015136318,0.00069216744],"domain_scores_gemma":[0.988996,0.0085082585,0.0010002475,0.00041460767,0.00043273217,0.00064814417],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0062052524,0.0005829529,0.0019642904,0.000492045,0.00024893123,0.000074799114,0.00019322189,0.00038713787,0.000041736403],"category_scores_gemma":[0.0029486718,0.00043601525,0.00059497735,0.00051357906,0.00079296186,0.0003781343,0.0001557606,0.001987741,0.0000066819907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023948953,0.0064378064,0.9421313,0.000107625005,0.0007174148,0.000015239309,0.0003083479,0.00010365018,0.0026813007,0.000010756903,0.0000092776645,0.023528319],"study_design_scores_gemma":[0.049681712,0.0049618324,0.93823254,0.003310843,0.00011822741,0.000005295482,0.00031042943,0.001815962,0.0011079118,0.000025094814,0.000011329498,0.00041882767],"about_ca_topic_score_codex":0.00043892273,"about_ca_topic_score_gemma":0.00032972972,"teacher_disagreement_score":0.025732758,"about_ca_system_score_codex":0.0001759357,"about_ca_system_score_gemma":0.00024308792,"threshold_uncertainty_score":0.99980915},"labels":[],"label_agreement":null},{"id":"W2995950133","doi":"10.1177/2055217319894360","title":"Identifying people with multiple sclerosis in the Canadian Primary Care Sentinel Surveillance Network","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Manitoba Health; University of Manitoba","funders":"Research Manitoba","keywords":"Medicine; Multiple sclerosis; Medical diagnosis; Primary care; Epidemiology; Cohort; Population; Medical prescription; Family medicine; Internal medicine; Pathology; Environmental health; Nursing","score_opus":0.12411031433271204,"score_gpt":0.34055021199178576,"score_spread":0.21643989765907373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995950133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99075943,0.004114831,0.000046112265,0.0026259674,0.00030209532,0.0011405018,0.00005443125,0.000028340462,0.000928275],"genre_scores_gemma":[0.9948815,0.0012759906,0.0019430991,0.0010067925,0.00059778587,0.000070844704,0.0001383877,0.000050007468,0.000035570494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957409,0.0004862685,0.0010165115,0.0006350342,0.0012678788,0.00085342344],"domain_scores_gemma":[0.9973331,0.0012903974,0.00020296597,0.00033914106,0.0002623126,0.00057208876],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015478218,0.0003860056,0.00076593854,0.00019183775,0.0009020219,0.0003009902,0.0003143868,0.00020487573,0.00016782702],"category_scores_gemma":[0.00013807316,0.00026440423,0.00034462198,0.0005083394,0.00033051512,0.0003398744,0.00007375008,0.0011870172,0.000039106955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009468102,0.00043507802,0.9909485,0.00007653006,0.00017969972,0.00001923906,0.0024569107,0.00021062465,0.0024576639,0.000024144587,0.00024647213,0.0019983368],"study_design_scores_gemma":[0.0102474475,0.00041761852,0.9829252,0.000656114,0.000037932434,0.000086817905,0.0033522886,0.0013433022,0.00011935741,0.000013206942,0.0004836187,0.00031709037],"about_ca_topic_score_codex":0.00554097,"about_ca_topic_score_gemma":0.10068382,"teacher_disagreement_score":0.09514285,"about_ca_system_score_codex":0.00029070504,"about_ca_system_score_gemma":0.00042979253,"threshold_uncertainty_score":0.9999808},"labels":[],"label_agreement":null},{"id":"W3012254007","doi":"10.1177/2055217320911939","title":"An exploratory analysis of the efficacy of ocrelizumab in patients with multiple sclerosis with increased disability","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Allergan; EMD Serono; Genentech; MedDay Pharmaceuticals; Sanofi; Bayer HealthCare; Chugai Pharmaceutical; Mallinckrodt Pharmaceuticals; Acorda Therapeutics; Mylan; TG Therapeutics; Sanofi Genzyme; F. Hoffmann-La Roche; Teva Pharmaceutical Industries; Biogen; Celgene; University of Texas Health Science Center at Houston","keywords":"Ocrelizumab; Medicine; Expanded Disability Status Scale; Multiple sclerosis; Placebo; Internal medicine; Interferon beta-1a; Oncology; Clinical trial; Physical therapy; Immunology; Pathology; Rituximab; Alternative medicine","score_opus":0.12643456212150755,"score_gpt":0.345705107309352,"score_spread":0.21927054518784445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012254007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979243,0.00022568728,0.0001156689,0.0006875971,0.000032131513,0.00079482753,0.00019078354,0.000015784753,0.000013172147],"genre_scores_gemma":[0.9978713,0.000109862405,0.001658389,0.00016440748,0.00007943184,0.000025389094,0.0000610414,0.000029771985,4.207936e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959321,0.00057162216,0.0013407686,0.0005441159,0.0012903167,0.00032109377],"domain_scores_gemma":[0.99716467,0.0011881305,0.000421575,0.00036194836,0.00033967436,0.0005240254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000638614,0.00030800313,0.0010686845,0.00014082475,0.00021468994,0.000032028405,0.0002714058,0.00012180863,0.000114269256],"category_scores_gemma":[0.0005332029,0.00018385696,0.00046008677,0.0010681939,0.001310538,0.0003211684,0.000075727454,0.0005786855,7.2764044e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0134122055,0.005327888,0.9641595,0.000036922447,0.0012709097,0.0000011337735,0.0016554358,0.0006377893,0.011884809,0.0000052852024,0.0000068813024,0.0016012432],"study_design_scores_gemma":[0.025012732,0.0024630623,0.9602889,0.0002991517,0.00051288464,7.869497e-7,0.0010882755,0.005791588,0.0043401173,0.0000016865775,0.0000055961195,0.00019525117],"about_ca_topic_score_codex":0.000116482835,"about_ca_topic_score_gemma":0.00023267139,"teacher_disagreement_score":0.011600527,"about_ca_system_score_codex":0.00007483893,"about_ca_system_score_gemma":0.00014449314,"threshold_uncertainty_score":0.7497469},"labels":[],"label_agreement":null},{"id":"W3015049303","doi":"10.1177/2055217320907951","title":"The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing–remitting multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Fingolimod; Medicine; Multiple sclerosis; Expanded Disability Status Scale; Magnetic resonance imaging; Relapsing remitting; Internal medicine; Physical therapy; Pediatrics; Immunology","score_opus":0.17645691073053707,"score_gpt":0.382740791297774,"score_spread":0.20628388056723693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015049303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955365,0.0010507065,0.00008507532,0.0017146778,0.00014319048,0.0013662565,0.00004943605,0.000031128966,0.00002300236],"genre_scores_gemma":[0.9979322,0.0005754741,0.00088157615,0.00019083632,0.00029831834,0.000038751405,0.00002393448,0.00005260269,0.0000063241646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99526405,0.00041111966,0.0017098758,0.00063242,0.0013437773,0.0006387458],"domain_scores_gemma":[0.99590796,0.0025208038,0.00042865827,0.00026267848,0.00032027857,0.0005595994],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012380112,0.00038187572,0.00084140344,0.000078192585,0.0008507002,0.0001487776,0.00030365054,0.00014727177,0.000038133137],"category_scores_gemma":[0.0013779321,0.00025209325,0.00035286386,0.00039963092,0.00073066377,0.00029913013,0.0001811321,0.0010672081,0.000005762022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008199488,0.003990745,0.95940685,0.00003082369,0.0004139641,0.000007150418,0.0041350718,0.000061669496,0.003577146,0.000002837867,0.000024893034,0.02014935],"study_design_scores_gemma":[0.038831607,0.0027935184,0.95347005,0.00061599596,0.00007143872,0.0000043601367,0.0020191928,0.00091427244,0.0010128771,0.0000020777336,0.000016197657,0.00024841772],"about_ca_topic_score_codex":0.000040320563,"about_ca_topic_score_gemma":0.000096965305,"teacher_disagreement_score":0.03063212,"about_ca_system_score_codex":0.00008312735,"about_ca_system_score_gemma":0.000103594386,"threshold_uncertainty_score":0.99999315},"labels":[],"label_agreement":null},{"id":"W3040620803","doi":"10.1177/2055217320926613","title":"Short-term outcomes of pediatric multiple sclerosis patients treated with alemtuzumab at a Canadian University multiple sclerosis clinic","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Alemtuzumab; Multiple sclerosis; Medicine; Expanded Disability Status Scale; Pediatrics; Internal medicine; Psychiatry; Transplantation","score_opus":0.21394610092173535,"score_gpt":0.3359127337161579,"score_spread":0.12196663279442252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040620803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99455684,0.0007255651,0.000051945277,0.0019186031,0.00016887374,0.001346234,0.00100355,0.00008167797,0.00014669138],"genre_scores_gemma":[0.99352795,0.003328115,0.0018921472,0.00041547907,0.0003778884,0.000024397717,0.00026055824,0.00009777173,0.00007570742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940953,0.00045897614,0.0018297982,0.0011047247,0.0015139264,0.0009972397],"domain_scores_gemma":[0.9943239,0.0017093128,0.00047913045,0.00038685842,0.00062492647,0.002475886],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005877963,0.0007309137,0.0015719788,0.00041600104,0.0010730162,0.00009355012,0.00044301982,0.000403373,0.0005639896],"category_scores_gemma":[0.00073010253,0.0006054501,0.0009110071,0.0006962563,0.0008265783,0.00051971164,0.00021899187,0.0010118979,0.00005556893],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005237139,0.0017967039,0.9807543,0.000065584405,0.0009872307,0.000033993005,0.00081831333,0.000023356959,0.006246197,0.0000025575964,0.0005635668,0.003471014],"study_design_scores_gemma":[0.02544731,0.0022473186,0.966785,0.0002507164,0.0004889072,0.000013538799,0.0006733662,0.0012732424,0.0019864724,0.0000010666596,0.00024085403,0.00059219106],"about_ca_topic_score_codex":0.002338096,"about_ca_topic_score_gemma":0.005574466,"teacher_disagreement_score":0.020210173,"about_ca_system_score_codex":0.0004791205,"about_ca_system_score_gemma":0.0004438291,"threshold_uncertainty_score":0.9996397},"labels":[],"label_agreement":null},{"id":"W3092637296","doi":"10.1177/2055217320959806","title":"Environmental enrichment alleviates the deleterious effects of stress in experimental autoimmune encephalomyelitis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Fondation pour la Recherche Médicale; Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques","keywords":"Multiple sclerosis; Experimental autoimmune encephalomyelitis; Encephalomyelitis; Medicine; Incidence (geometry); Animal model; Immunology; Internal medicine","score_opus":0.08212622809739435,"score_gpt":0.33615484850536415,"score_spread":0.2540286204079698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092637296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792197,0.016152969,0.00006934286,0.0034943412,0.00016415797,0.00079604593,0.00004224731,0.000018601073,0.000042594642],"genre_scores_gemma":[0.99407744,0.004028132,0.00094415905,0.0005159748,0.0003064947,0.00007012848,0.000022585671,0.00002821382,0.0000068885215],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967832,0.00033791366,0.0011946814,0.00043519607,0.0008533554,0.0003956685],"domain_scores_gemma":[0.9981973,0.0010050184,0.00021671577,0.0001605837,0.000033048796,0.0003873442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003859265,0.00030515602,0.00066527416,0.000072487426,0.0002652835,0.00005165698,0.00022118744,0.00012170106,0.00024138106],"category_scores_gemma":[0.00019348771,0.00021618721,0.00038513375,0.00013544437,0.00067874085,0.00019637782,0.00014563359,0.00063736126,0.000009546024],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013997356,0.002389257,0.25427243,0.00007013322,0.00034953852,0.000048067468,0.005517795,0.00003636307,0.7205634,0.000028788569,0.00006415476,0.015260343],"study_design_scores_gemma":[0.009878932,0.0017843279,0.8761375,0.0003044616,0.0000467868,0.00003577858,0.0030303146,0.0021157404,0.10623949,0.00001143652,0.00020876476,0.00020648855],"about_ca_topic_score_codex":0.000042418153,"about_ca_topic_score_gemma":0.0000051570664,"teacher_disagreement_score":0.62186503,"about_ca_system_score_codex":0.00008405202,"about_ca_system_score_gemma":0.000058927,"threshold_uncertainty_score":0.88158584},"labels":[],"label_agreement":null},{"id":"W3093363057","doi":"10.1177/2055217320964940","title":"The feasibility of assessing cognitive and motor function in multiple sclerosis patients using robotics","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"Canadian Institutes of Health Research; GlaxoSmithKline","keywords":"Robotics; Multiple sclerosis; Cognition; Motor function; Artificial intelligence; Physical medicine and rehabilitation; Motor learning; Psychology; Neuroscience; Computer science; Medicine; Robot; Psychiatry","score_opus":0.42009798668849724,"score_gpt":0.4216420065188642,"score_spread":0.0015440198303669495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093363057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994958,0.0017916309,0.00096310006,0.0012782144,0.00015863062,0.00075631234,0.000060386796,0.000014461332,0.000019307741],"genre_scores_gemma":[0.9953308,0.0012454705,0.0029257396,0.00022041272,0.00021991444,0.000012623611,0.000017569759,0.00002554396,0.0000019388892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968649,0.00039757811,0.0012135721,0.000442833,0.0007372513,0.00034385902],"domain_scores_gemma":[0.9966771,0.002159252,0.00029532248,0.00010366268,0.00033715053,0.00042752136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088844105,0.0002486382,0.00056616706,0.000078130804,0.00061491155,0.00012442196,0.00009387184,0.00014325132,0.000022059105],"category_scores_gemma":[0.0017229435,0.00018281104,0.0002470664,0.00022241105,0.00076853624,0.00038619526,0.000103310085,0.0006562451,0.0000013459078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032143807,0.0009509536,0.93298477,0.00003991195,0.00016937537,0.0000015094074,0.0005555924,0.00006089547,0.04971708,0.000009425189,0.000009017733,0.012287084],"study_design_scores_gemma":[0.012659967,0.0010851147,0.9518005,0.00044427713,0.000092909315,0.0000045243764,0.0019122652,0.030477349,0.001323997,0.000028536844,0.0000086765385,0.00016188726],"about_ca_topic_score_codex":0.000039188242,"about_ca_topic_score_gemma":0.000026742819,"teacher_disagreement_score":0.048393086,"about_ca_system_score_codex":0.00007573413,"about_ca_system_score_gemma":0.00010266166,"threshold_uncertainty_score":0.7454818},"labels":[],"label_agreement":null},{"id":"W3116218681","doi":"10.1177/2055217320972137","title":"Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Sanofi","keywords":"Alemtuzumab; Medicine; Multiple sclerosis; Expanded Disability Status Scale; Internal medicine; Confidence interval; Relapsing remitting; Progressive disease; Disease; Immunology; Transplantation","score_opus":0.16019352899797554,"score_gpt":0.34929165858651756,"score_spread":0.18909812958854202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3116218681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933899,0.0018913555,0.0002630026,0.0014932255,0.00035460296,0.0018423804,0.0005978531,0.00011690389,0.000050749146],"genre_scores_gemma":[0.9883063,0.0006907087,0.008692395,0.0010216702,0.00072574866,0.00010368196,0.00033075933,0.000117233394,0.000011535396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9928847,0.0004532922,0.002750741,0.0011929176,0.0018851917,0.00083314115],"domain_scores_gemma":[0.9950565,0.0015339706,0.0009442115,0.00033842417,0.0007164609,0.0014104387],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00082176947,0.0006446788,0.0013872446,0.00024390277,0.00064626,0.00016435594,0.00034460166,0.00038526638,0.0005824553],"category_scores_gemma":[0.0027454179,0.0005892128,0.0007803836,0.0005588874,0.0006401949,0.0006489879,0.00030055392,0.0012791037,0.000040178442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041053304,0.0015832231,0.75642353,0.00006846778,0.0006358014,0.000012441164,0.0023215364,0.00005134214,0.20352094,0.0000029018815,0.00046942278,0.030805077],"study_design_scores_gemma":[0.02117913,0.0017147496,0.9119938,0.001747199,0.00019533356,0.000006476347,0.0010450064,0.006971043,0.054412857,0.000009963717,0.00019128443,0.00053315266],"about_ca_topic_score_codex":0.00027581392,"about_ca_topic_score_gemma":0.000034156947,"teacher_disagreement_score":0.1555703,"about_ca_system_score_codex":0.00021171692,"about_ca_system_score_gemma":0.0002229638,"threshold_uncertainty_score":0.9996559},"labels":[],"label_agreement":null},{"id":"W3134392354","doi":"10.1177/2055217321990852","title":"Early MRI outcomes in participants with a first clinical demyelinating event at risk of multiple sclerosis in the ORACLE-MS study","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"EMD Serono","keywords":"Cladribine; Multiple sclerosis; Medicine; Placebo; Lesion; Magnetic resonance imaging; Nuclear medicine; Post-hoc analysis; Internal medicine; Radiology; Surgery; Pathology","score_opus":0.2575479572732252,"score_gpt":0.42546085738620326,"score_spread":0.16791290011297805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134392354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944042,0.0013924731,0.00009400774,0.0025757356,0.0001507284,0.0012580948,0.00007432819,0.000017073939,0.000033366352],"genre_scores_gemma":[0.99363893,0.002855056,0.0029060703,0.0001786266,0.0001966697,0.00014940188,0.000015048957,0.00004210874,0.000018063593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9921727,0.0018696082,0.0029069947,0.00078475464,0.0015567009,0.00070920936],"domain_scores_gemma":[0.9905507,0.007767829,0.0005558607,0.00040705717,0.00029084858,0.00042768253],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00493272,0.00040922593,0.0013452929,0.0001897178,0.00054048665,0.00009511088,0.00029304734,0.00020281236,0.00013105877],"category_scores_gemma":[0.0029471184,0.00026825743,0.000574018,0.0005437208,0.00062139006,0.00027762272,0.00020436941,0.0014076857,0.000009035042],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028402105,0.010981012,0.9754723,0.000030346619,0.00062046474,0.000089516645,0.005332141,0.00022788587,0.001213971,0.0000045077154,0.00002679541,0.0031608567],"study_design_scores_gemma":[0.02793438,0.0022046845,0.9570968,0.00070564874,0.00018007665,0.000031145228,0.0073189307,0.0035121283,0.0006970097,0.000015510748,0.00003280361,0.0002708472],"about_ca_topic_score_codex":0.00044513753,"about_ca_topic_score_gemma":0.007290849,"teacher_disagreement_score":0.02509417,"about_ca_system_score_codex":0.0001335296,"about_ca_system_score_gemma":0.0002157273,"threshold_uncertainty_score":0.99997693},"labels":[],"label_agreement":null},{"id":"W3168177144","doi":"10.1177/20552173211015503","title":"Relapse recovery in multiple sclerosis: Effect of treatment and contribution to long-term disability","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Race to Erase MS; Mallinckrodt Pharmaceuticals; National Multiple Sclerosis Society","keywords":"Medicine; Expanded Disability Status Scale; Multiple sclerosis; Disease; Pediatrics; Physical therapy; Internal medicine; Psychiatry","score_opus":0.1422290573835009,"score_gpt":0.3898073066572257,"score_spread":0.2475782492737248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168177144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925143,0.004387365,0.00010712684,0.0016304828,0.00021306865,0.000983814,0.00012578831,0.000019502952,0.000018522172],"genre_scores_gemma":[0.99329334,0.0051941895,0.0009748248,0.00010268178,0.00022189776,0.000096775846,0.00007290628,0.000025776522,0.000017591337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964382,0.0006858602,0.0013044435,0.0006404813,0.00049774756,0.0004332412],"domain_scores_gemma":[0.9963352,0.0024559812,0.00017092797,0.00024388387,0.00020031544,0.00059366366],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012009693,0.00034501715,0.0010344681,0.00011335173,0.0002904903,0.00007109651,0.00008196536,0.00020135005,0.00011205034],"category_scores_gemma":[0.0014504114,0.00026963066,0.00043623228,0.00026245884,0.0005236624,0.00025189997,0.000096579504,0.00043515878,0.000005794425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00491502,0.0017574064,0.8251056,0.00005639892,0.00027213353,0.000015930244,0.0002642211,0.00002669401,0.14084451,0.000008836162,0.0000127684425,0.02672049],"study_design_scores_gemma":[0.019952647,0.003810307,0.9080295,0.00079323305,0.00010499512,0.00005981064,0.00013313918,0.00043782953,0.06642441,0.000015128453,0.000030905576,0.00020810543],"about_ca_topic_score_codex":0.00007380709,"about_ca_topic_score_gemma":0.00026048243,"teacher_disagreement_score":0.082923904,"about_ca_system_score_codex":0.00032824697,"about_ca_system_score_gemma":0.00012261179,"threshold_uncertainty_score":0.99997556},"labels":[],"label_agreement":null},{"id":"W3180459776","doi":"10.1177/20552173211029672","title":"Prioritizing the healthcare access concerns of Canadians with MS","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Health care; Descriptive statistics; Quality (philosophy); Business; Medicine; Nursing; Family medicine; Political science","score_opus":0.2766300272571652,"score_gpt":0.4396019545093432,"score_spread":0.16297192725217802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180459776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9717223,0.0055873995,0.0001495099,0.021615723,0.00015736371,0.0003568795,0.00008592567,0.000013433503,0.00031147306],"genre_scores_gemma":[0.99448365,0.002495143,0.0016643902,0.00080258877,0.00045546316,0.000018215245,0.000020718046,0.000021790296,0.00003802703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976465,0.0002472346,0.0007430587,0.00030849563,0.0007269475,0.0003277591],"domain_scores_gemma":[0.9979684,0.0008370028,0.00016454795,0.00018124055,0.00040946977,0.00043939182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051231124,0.00017831611,0.00046873663,0.000053354608,0.0004861521,0.00009809098,0.00015390318,0.00009122417,0.00014449129],"category_scores_gemma":[0.0002068312,0.000112648464,0.00023063077,0.00020927619,0.0005982643,0.0001962393,0.00006483066,0.0006093168,0.0000016763044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013594972,0.00087636645,0.9423498,0.00009342499,0.00075798895,0.00009002189,0.0025556015,0.000018631275,0.033765648,0.0004710116,0.00033755373,0.017324459],"study_design_scores_gemma":[0.005998525,0.0005672335,0.9810201,0.0005135197,0.000074124524,0.0002475493,0.0029095728,0.0004921399,0.0069267135,0.0000504132,0.0010453034,0.00015482742],"about_ca_topic_score_codex":0.0010971823,"about_ca_topic_score_gemma":0.0024711604,"teacher_disagreement_score":0.03867028,"about_ca_system_score_codex":0.000063761196,"about_ca_system_score_gemma":0.0005474476,"threshold_uncertainty_score":0.4593671},"labels":[],"label_agreement":null},{"id":"W3186009020","doi":"10.1177/20552173211029674","title":"A retrospective analysis of changes in lymphocyte levels in patients with multiple sclerosis during and after Tecfidera® treatment","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Burnaby Hospital; Fraser Health","funders":"","keywords":"Discontinuation; CD8; Multiple sclerosis; Lymphocyte; Immune system; Medicine; CD4-CD8 Ratio; Immunology; Internal medicine; T cell; Lymphocyte subsets","score_opus":0.10685758854566958,"score_gpt":0.34254754273791105,"score_spread":0.23568995419224148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186009020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996853,0.0018615018,0.000014734609,0.00049929187,0.000045030807,0.000489724,0.00020734326,0.000010416429,0.000018980367],"genre_scores_gemma":[0.9953929,0.0026972054,0.0016032007,0.00007209363,0.00006929285,0.00008310834,0.000039554216,0.000027273873,0.000015381582],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99702084,0.00024722188,0.0009699738,0.0006282963,0.0007227844,0.00041085904],"domain_scores_gemma":[0.99859655,0.0004584641,0.00019495297,0.00019228605,0.00025334855,0.00030439775],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038016692,0.00032444688,0.0011155856,0.0005319616,0.00015898718,0.000057093897,0.00006283021,0.000146964,0.00017526922],"category_scores_gemma":[0.0002207609,0.00025182773,0.00027948656,0.00078024453,0.00035909915,0.00021605115,0.00007139884,0.00033499554,8.128589e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037946275,0.0025410103,0.9719419,0.000027203747,0.0013413624,0.00003330911,0.0014694092,0.000055264194,0.014907783,0.0000028539896,6.535405e-7,0.0038846643],"study_design_scores_gemma":[0.029515708,0.00095258286,0.95723337,0.0005206405,0.00030701805,0.000008354989,0.0007142443,0.0011395852,0.009368493,0.0000054245215,0.0000052379887,0.00022932565],"about_ca_topic_score_codex":0.00014028045,"about_ca_topic_score_gemma":0.0029924363,"teacher_disagreement_score":0.02572108,"about_ca_system_score_codex":0.0003626435,"about_ca_system_score_gemma":0.000116443196,"threshold_uncertainty_score":0.9999934},"labels":[],"label_agreement":null},{"id":"W3186349681","doi":"10.1177/20552173211024298","title":"Treatment-emergent adverse events occurring early in the treatment course of cladribine tablets in two phase 3 trials in multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Cladribine; Multiple sclerosis; Adverse effect; Medicine; Phase (matter); Pharmacology; Internal medicine; Psychiatry; Chemistry","score_opus":0.3857309654780424,"score_gpt":0.4771650838811986,"score_spread":0.09143411840315618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186349681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99181306,0.004710477,0.00003483698,0.0014708255,0.00025942823,0.0014148325,0.0002475061,0.000011611815,0.000037395315],"genre_scores_gemma":[0.9873322,0.010777103,0.0011323462,0.00012445702,0.0002757193,0.00021756298,0.00009048635,0.000033010365,0.00001707649],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99303985,0.0018127124,0.0029771323,0.0006623422,0.0008661588,0.00064182223],"domain_scores_gemma":[0.9953969,0.00333948,0.00043341215,0.00032351585,0.00015589557,0.00035078116],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026803366,0.0004756314,0.0017268906,0.00031976154,0.00021771554,0.000035457113,0.000184708,0.00015374766,0.00022358501],"category_scores_gemma":[0.00084328576,0.00032090003,0.0008573992,0.00058901595,0.00028289857,0.00029953953,0.00004910604,0.0005758475,0.000005498128],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004329299,0.02240516,0.86623544,0.000022019678,0.00044951114,0.00012469482,0.004064796,0.00027714812,0.07728715,0.000013115282,0.0000142550425,0.024777398],"study_design_scores_gemma":[0.09235834,0.002290707,0.878574,0.0007241243,0.00013437164,0.00003816195,0.0050426666,0.0041374713,0.016206104,0.000024045288,0.00021056272,0.00025941638],"about_ca_topic_score_codex":0.0007844931,"about_ca_topic_score_gemma":0.0023131478,"teacher_disagreement_score":0.08802905,"about_ca_system_score_codex":0.00038335985,"about_ca_system_score_gemma":0.00030436652,"threshold_uncertainty_score":0.9999243},"labels":[],"label_agreement":null},{"id":"W3186380202","doi":"10.1177/20552173211032313","title":"The road to conception for women with multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of British Columbia","funders":"","keywords":"Pregnancy; Multiple sclerosis; Prospective cohort study; Medicine; Psychiatry; Surgery","score_opus":0.1923408582830517,"score_gpt":0.38959881789121203,"score_spread":0.19725795960816034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186380202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98354924,0.0021102414,0.0018062297,0.010765782,0.00034224265,0.0011152187,0.0001125195,0.000045045686,0.00015351055],"genre_scores_gemma":[0.98671037,0.0020573481,0.008655128,0.00089767366,0.00089160824,0.0003887884,0.00003436203,0.000049931776,0.00031476564],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99651426,0.00025445636,0.0009933315,0.0006072,0.0009167121,0.0007140487],"domain_scores_gemma":[0.9961215,0.0019551434,0.00017116012,0.00027664518,0.000617087,0.00085842866],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0011924674,0.0003260922,0.00060095364,0.00007685662,0.0014271317,0.00028045854,0.00017764413,0.00014619036,0.00015156514],"category_scores_gemma":[0.0009696187,0.00021368451,0.00032626453,0.00026907123,0.00053269695,0.00024224169,0.000089320434,0.00053313386,0.000018823244],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022625823,0.0031637535,0.2782657,0.000084685555,0.0018794141,0.000027814565,0.0043952106,0.00016274268,0.3981728,0.00023283006,0.0032087017,0.28778052],"study_design_scores_gemma":[0.01763611,0.0024188082,0.9448785,0.00037532698,0.00007380631,0.000086041495,0.0057765082,0.0020278976,0.015022669,0.000079997066,0.011259573,0.0003647468],"about_ca_topic_score_codex":0.000016479971,"about_ca_topic_score_gemma":0.000108313856,"teacher_disagreement_score":0.6666128,"about_ca_system_score_codex":0.00016895337,"about_ca_system_score_gemma":0.00024658605,"threshold_uncertainty_score":0.99987286},"labels":[],"label_agreement":null},{"id":"W3186595272","doi":"10.1177/20552173211029966","title":"Preliminary testing of a patient decision aid for patients with relapsing-remitting multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; St. Paul's Hospital; University of British Columbia","funders":"VGH and UBC Hospital Foundation","keywords":"Thematic analysis; Medicine; Relapsing remitting; Decision aids; Qualitative research; Multiple sclerosis; Psychology; Alternative medicine; Psychiatry; Pathology","score_opus":0.3561606465641006,"score_gpt":0.4171070059915418,"score_spread":0.0609463594274412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186595272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922059,0.0034402874,0.0013874818,0.00063809886,0.00076341926,0.0012519615,0.00019857932,0.000043370892,0.00007089417],"genre_scores_gemma":[0.8426349,0.00014881266,0.1563576,0.0003565013,0.00017090049,0.00015274048,0.000119234544,0.000050578692,0.000008685031],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947674,0.0008963419,0.0025252104,0.0005459372,0.0007500881,0.000514978],"domain_scores_gemma":[0.98479515,0.011961753,0.0011287223,0.00038936717,0.0013251407,0.00039988503],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0006182291,0.00030014946,0.0005948545,0.00011251572,0.001846608,0.00003712996,0.00024903478,0.00029666407,0.000087829205],"category_scores_gemma":[0.0030033116,0.00025698976,0.00026783667,0.00030239992,0.00022653156,0.00040894764,0.0001810476,0.00094523816,0.000005477802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033414897,0.0015422361,0.9622341,0.00010703118,0.00009407961,0.0000010779577,0.0039924663,0.00013782796,0.0015419389,0.000054897642,0.00012573943,0.026827151],"study_design_scores_gemma":[0.025121609,0.0031339722,0.943183,0.0060326736,0.00010908157,0.0000114119175,0.011474722,0.006896872,0.0019966392,0.0005179625,0.0010126013,0.0005094252],"about_ca_topic_score_codex":0.000047307556,"about_ca_topic_score_gemma":0.000035057834,"teacher_disagreement_score":0.15497012,"about_ca_system_score_codex":0.00013460108,"about_ca_system_score_gemma":0.00043717216,"threshold_uncertainty_score":0.99998826},"labels":[],"label_agreement":null},{"id":"W3198306866","doi":"10.1177/20552173211038030","title":"Research interrupted: The impact of the COVID-19 pandemic on multiple sclerosis research in the field of rehabilitation and quality of life","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Memorial University of Newfoundland","funders":"","keywords":"Pandemic; Coronavirus disease 2019 (COVID-19); Rehabilitation; Wilcoxon signed-rank test; Quality of life (healthcare); 2019-20 coronavirus outbreak; Psychology; Multiple sclerosis; Medicine; Gerontology; Nursing; Physical therapy; Disease; Psychiatry; Pathology","score_opus":0.6494420521584078,"score_gpt":0.5775456845627955,"score_spread":0.07189636759561224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198306866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97847784,0.0020905018,0.000021359703,0.018362913,0.00006654848,0.00080347084,0.00007523876,0.000004262851,0.00009788693],"genre_scores_gemma":[0.99684817,0.0023167192,0.00026550572,0.00036413138,0.00012589055,0.000050177667,0.0000072198077,0.000014079599,0.00000813055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98992914,0.005645244,0.0016153213,0.0003972438,0.0020263842,0.0003866745],"domain_scores_gemma":[0.9419093,0.056302518,0.00029237504,0.00046433305,0.0007532742,0.00027815762],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.014694353,0.00018240072,0.0006266018,0.0002284066,0.00055272557,0.00004856905,0.00038089085,0.0001815827,0.00009451285],"category_scores_gemma":[0.027474286,0.00009192336,0.00052758295,0.00083757757,0.002333755,0.000121995305,0.00021756047,0.001753476,8.390747e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038067559,0.0017049509,0.909498,0.00011188939,0.00020079552,9.258389e-7,0.005342978,0.00009273385,0.07549719,0.00018361543,0.0005015742,0.0030586284],"study_design_scores_gemma":[0.0062186136,0.0017742078,0.97310954,0.00052744854,0.000015806789,0.000010928455,0.014006572,0.00058025133,0.0033123123,0.00031183357,0.000051825984,0.00008067996],"about_ca_topic_score_codex":0.0017816216,"about_ca_topic_score_gemma":0.0008209079,"teacher_disagreement_score":0.072184876,"about_ca_system_score_codex":0.00013577424,"about_ca_system_score_gemma":0.0006088075,"threshold_uncertainty_score":0.9807177},"labels":[],"label_agreement":null},{"id":"W4200041687","doi":"10.1177/20552173211065730","title":"Season of birth is associated with multiple sclerosis and disease severity","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Vetenskapsrådet; Hjärnfonden; Horizon 2020 Framework Programme; Knut och Alice Wallenbergs Stiftelse; Multiple Sclerosis Society of Canada","keywords":"Season of birth; Medicine; Multiple sclerosis; Incidence (geometry); Vitamin D and neurology; Breastfeeding; Population; Demography; Pediatrics; Cohort study; Disease; Cohort; Logistic regression; Internal medicine; Environmental health; Immunology","score_opus":0.15325505423640565,"score_gpt":0.35890842618771174,"score_spread":0.2056533719513061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200041687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886095,0.005445928,0.0001572704,0.0047103036,0.00010785628,0.00041036925,0.0004213325,0.00003524574,0.00010221177],"genre_scores_gemma":[0.99162906,0.004083031,0.0031817374,0.00061073445,0.0001914974,0.000025799693,0.000077129036,0.000043004686,0.00015801654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99647325,0.0003472728,0.0009793482,0.00062787696,0.0011215637,0.00045068335],"domain_scores_gemma":[0.99647945,0.001275541,0.0002761309,0.00023956296,0.0005298052,0.0011994948],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006802853,0.0003521862,0.0008421531,0.00010650509,0.00048192716,0.00010218671,0.00010857386,0.00016788779,0.00034496447],"category_scores_gemma":[0.001448026,0.00028053857,0.0003782539,0.00030193586,0.000814074,0.00031081677,0.000115574774,0.0006389152,0.0000036032698],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031214112,0.0025807014,0.95578194,0.00009013464,0.0009116017,0.00005325879,0.00076581043,0.000007185551,0.03083794,0.000031366046,0.00048058818,0.005338085],"study_design_scores_gemma":[0.014009946,0.00044477786,0.9711395,0.0010416581,0.00019369023,0.000042888863,0.000721353,0.0023481632,0.009333644,0.00006968354,0.00035302417,0.0003016611],"about_ca_topic_score_codex":0.000023293404,"about_ca_topic_score_gemma":0.00007720354,"teacher_disagreement_score":0.021504296,"about_ca_system_score_codex":0.00006876173,"about_ca_system_score_gemma":0.00034781147,"threshold_uncertainty_score":0.99996465},"labels":[],"label_agreement":null},{"id":"W4200169784","doi":"10.1177/20552173211051855","title":"Multiple Sclerosis International Federation guideline methodology for off-label treatments for multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Guideline; Checklist; Grading (engineering); Transparency (behavior); Medicine; Judgement; Population; Medical education; Public relations; Psychology; Political science; Environmental health; Engineering; Pathology","score_opus":0.6834472202916444,"score_gpt":0.5261637888695437,"score_spread":0.15728343142210066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200169784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78110313,0.0032467616,0.1783571,0.02951154,0.003379588,0.00281201,0.0013999715,0.00011992877,0.0000699755],"genre_scores_gemma":[0.6676124,0.0019238846,0.32262895,0.003245768,0.0017952689,0.00028383266,0.002255926,0.000083318126,0.00017070331],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9929038,0.00058710744,0.003984911,0.0010763633,0.0008378482,0.0006099643],"domain_scores_gemma":[0.9864201,0.010242,0.00091029576,0.00032478772,0.0014891945,0.00061362993],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030789138,0.00053278875,0.0010606177,0.00019068972,0.00092036667,0.00029365192,0.00022651978,0.00045050343,0.00050738925],"category_scores_gemma":[0.008804832,0.0005021875,0.0009914516,0.00021263758,0.00025580078,0.0007898427,0.0000995259,0.0005643563,0.000016379794],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016961703,0.00916788,0.14813724,0.00006595608,0.0032457241,0.00001728262,0.0006254738,0.00024677318,0.50150394,0.00035878227,0.009547106,0.31012213],"study_design_scores_gemma":[0.20692725,0.006292513,0.39597955,0.00094526174,0.0031958723,0.0006024321,0.005082871,0.2034795,0.13576339,0.002067624,0.037823893,0.0018398253],"about_ca_topic_score_codex":0.00007128232,"about_ca_topic_score_gemma":0.0002294666,"teacher_disagreement_score":0.36574057,"about_ca_system_score_codex":0.00024131604,"about_ca_system_score_gemma":0.00042866395,"threshold_uncertainty_score":0.999743},"labels":[],"label_agreement":null},{"id":"W4205295256","doi":"10.1177/20552173221074296","title":"Development of an indicator of smoking status for people with multiple sclerosis in administrative data","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"Research Manitoba","keywords":"Confounding; Medicine; Predictive value; Pulmonary disease; Disease; Environmental health; Smoking cessation; Tobacco control; Public health; Internal medicine; Pathology","score_opus":0.35258671803505,"score_gpt":0.43036655638331683,"score_spread":0.07777983834826685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205295256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963742,0.0008107153,0.00047111997,0.00028987433,0.00009129539,0.001008576,0.0009215572,0.000012315222,0.000020370726],"genre_scores_gemma":[0.9422482,0.00023634119,0.056757588,0.000050377173,0.00008408286,0.00017032088,0.00041492487,0.000034427467,0.0000037387829],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959216,0.00027914153,0.0015979916,0.0006014838,0.0011533437,0.00044644787],"domain_scores_gemma":[0.9973771,0.0012234115,0.0005071808,0.00032713983,0.00016325229,0.0004018893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017896688,0.00026085772,0.0008349255,0.00025344596,0.00052447716,0.000029833674,0.00035000656,0.00008604861,0.0001757263],"category_scores_gemma":[0.00032146968,0.00022014069,0.00015899907,0.0002998597,0.00037228773,0.00034546445,0.00025181944,0.00058511226,3.521196e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0095278695,0.005453528,0.88856757,0.000102838974,0.0006194307,0.0000046580994,0.007929352,0.000110985624,0.06618275,0.000029879044,0.000036289533,0.021434842],"study_design_scores_gemma":[0.017617516,0.0023723592,0.94546795,0.0002602494,0.00007207,0.00002144036,0.01170843,0.0054676495,0.016401622,0.000011070277,0.00036222738,0.00023742527],"about_ca_topic_score_codex":0.000075384174,"about_ca_topic_score_gemma":0.0004992943,"teacher_disagreement_score":0.05690036,"about_ca_system_score_codex":0.00012843226,"about_ca_system_score_gemma":0.000674739,"threshold_uncertainty_score":0.89770764},"labels":[],"label_agreement":null},{"id":"W4205669566","doi":"10.1177/20552173211070760","title":"Cervical Spinal Cord Atrophy can be Accurately Quantified Using Head Images","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Collaboration On Repair Discoveries; University of British Columbia","funders":"Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada; Multiple Sclerosis Society of Canada","keywords":"Spinal cord; Medicine; Cord; Atrophy; Magnetic resonance imaging; Central nervous system disease; Nuclear medicine; Radiology; Pathology; Internal medicine; Surgery","score_opus":0.514306738036913,"score_gpt":0.5040454166111249,"score_spread":0.010261321425788061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205669566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99035126,0.0016895289,0.00029417095,0.0064754738,0.00052643,0.00039157702,0.00014037277,0.000034883094,0.0000963269],"genre_scores_gemma":[0.9928354,0.00015833105,0.005039486,0.0011383694,0.00063867826,0.000025746485,0.000056172947,0.00004416312,0.00006367525],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.996237,0.00043549857,0.0010595695,0.00051503646,0.0012755418,0.00047735154],"domain_scores_gemma":[0.99854904,0.00029151287,0.00019147938,0.000191508,0.00015971476,0.00061671797],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009095248,0.0002719808,0.000540075,0.00017747798,0.0011261501,0.0001327747,0.00022642373,0.00010838441,0.0016199386],"category_scores_gemma":[0.000108375454,0.0002473424,0.0004747604,0.00029181308,0.00039045484,0.00020856458,0.00015319756,0.0014244869,0.000008085581],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11145307,0.004702021,0.26330477,0.000066777415,0.00064886484,0.0005247865,0.0002577192,0.00011725569,0.5865485,0.00047746065,0.00083865016,0.031060096],"study_design_scores_gemma":[0.018529246,0.028970208,0.9143318,0.00021583517,0.00024834432,0.0035851141,0.0026080913,0.008746809,0.01807556,0.00029507058,0.0036473759,0.0007465285],"about_ca_topic_score_codex":0.00014121544,"about_ca_topic_score_gemma":0.000013313085,"teacher_disagreement_score":0.651027,"about_ca_system_score_codex":0.00017581745,"about_ca_system_score_gemma":0.00031704083,"threshold_uncertainty_score":0.99999785},"labels":[],"label_agreement":null},{"id":"W4212934277","doi":"10.1177/20552173221078834","title":"Quantitative MRI findings indicate diffuse white matter damage in Susac Syndrome","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Retinal and Optic Conditions","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Collaboration On Repair Discoveries; University of British Columbia","funders":"Multiple Sclerosis Society of Canada","keywords":"White matter; Fractional anisotropy; Corpus callosum; Multiple sclerosis; Diffusion MRI; Myelin; Pathology; Medicine; Effective diffusion coefficient; Nuclear medicine; Magnetic resonance imaging; Internal medicine; Central nervous system; Radiology; Immunology","score_opus":0.0943923739671718,"score_gpt":0.34868010557157597,"score_spread":0.25428773160440415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212934277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99015087,0.0004414564,0.000113368646,0.0083290255,0.0002060008,0.00027829103,0.00009799828,0.000014466913,0.00036852178],"genre_scores_gemma":[0.9961104,0.00011304785,0.0022646138,0.00096316513,0.000063099724,0.000046842597,0.00008781488,0.000021832435,0.00032917436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788815,0.0002085123,0.0008209315,0.00032383215,0.0004945219,0.00026407698],"domain_scores_gemma":[0.99909425,0.0003725749,0.00012701596,0.00010189251,0.00003471398,0.00026955374],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000588257,0.00017789635,0.00038357236,0.00020070061,0.00046495354,0.00005618417,0.000116942014,0.00007018825,0.004498413],"category_scores_gemma":[0.00003246341,0.00015803498,0.00025492234,0.00021577362,0.00022589699,0.00019753049,0.000069684174,0.0008674457,0.000045201985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010994057,0.0020158212,0.9896679,0.000010833004,0.00010951774,0.0001918453,0.0013738137,0.000051916177,0.004438572,0.0002989464,0.00060809386,0.00013334007],"study_design_scores_gemma":[0.007043719,0.0011216447,0.9866422,0.00009042108,0.000053148124,0.00074328686,0.0019949838,0.0013078613,0.00012716783,0.00031796258,0.00037263837,0.00018497961],"about_ca_topic_score_codex":0.000016951912,"about_ca_topic_score_gemma":0.0000100694115,"teacher_disagreement_score":0.0073658605,"about_ca_system_score_codex":0.000070925205,"about_ca_system_score_gemma":0.000067431494,"threshold_uncertainty_score":0.9964116},"labels":[],"label_agreement":null},{"id":"W4225408553","doi":"10.1177/20552173221099181","title":"Researching COVID-19 in progressive MS requires a globally coordinated, multi-disciplinary and multi-stakeholder approach—perspectives from the International Progressive MS Alliance","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Alliance; Coronavirus disease 2019 (COVID-19); Stakeholder; Discipline; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Political science; Engineering ethics; Public relations; Engineering; Medicine; Virology; Law","score_opus":0.38754284603938016,"score_gpt":0.4547668075435914,"score_spread":0.06722396150421123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225408553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9490136,0.028353373,0.00066568947,0.019094003,0.00025673604,0.0018857896,0.0005741034,0.000059214934,0.00009748744],"genre_scores_gemma":[0.9776522,0.0020938034,0.018230958,0.0007590558,0.000508704,0.00049742905,0.00014770875,0.000045289795,0.00006486601],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994603,0.0010003379,0.0011544743,0.0010193092,0.0016014511,0.0006214587],"domain_scores_gemma":[0.99664843,0.0018045891,0.0003640033,0.000268998,0.00023006009,0.0006839399],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0022568954,0.00040339955,0.00062786805,0.00015861336,0.0017515335,0.00032671154,0.0006064468,0.0001375164,0.00045146444],"category_scores_gemma":[0.0015389379,0.00029627356,0.0002946479,0.00034330634,0.0015246639,0.00044517082,0.0008061772,0.0018681326,0.0000024633255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008023694,0.009169116,0.9298814,0.000053033673,0.0014267509,0.0004400271,0.023591708,0.00061574584,0.019547014,0.00020639916,0.00096411555,0.006080999],"study_design_scores_gemma":[0.025895962,0.0008950887,0.8971004,0.00034375297,0.00008099311,0.0003805902,0.035686072,0.038253363,0.00024780436,0.00014788627,0.0005410373,0.000427062],"about_ca_topic_score_codex":0.00033536274,"about_ca_topic_score_gemma":0.0001311618,"teacher_disagreement_score":0.037637617,"about_ca_system_score_codex":0.00042254874,"about_ca_system_score_gemma":0.0004311864,"threshold_uncertainty_score":0.9999489},"labels":[],"label_agreement":null},{"id":"W4280501079","doi":"10.1177/20552173221086662","title":"Fecal microbiota transplantation is safe and tolerable in patients with multiple sclerosis: A pilot randomized controlled trial","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; St Joseph's Health Care; Lawson Health Research Institute; London Health Sciences Centre; Western University","funders":"London Health Sciences Foundation","keywords":"Medicine; Intestinal permeability; Multiple sclerosis; Gut flora; Gastroenterology; Internal medicine; Randomized controlled trial; Transplantation; Feces; Fecal bacteriotherapy; Immunology; Biology; Antibiotics","score_opus":0.044974120161359966,"score_gpt":0.2874829487925395,"score_spread":0.24250882863117953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280501079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995563,0.0014018897,0.000153656,0.0004771213,0.00027574835,0.0019337612,0.00015318915,0.000006494303,0.00003517549],"genre_scores_gemma":[0.99688363,0.00083869434,0.00098349,0.0006758213,0.00015827229,0.00018086183,0.00021065181,0.000025841384,0.000042735322],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99711835,0.00071203714,0.0010915305,0.00047152254,0.00030370217,0.00030287277],"domain_scores_gemma":[0.9990658,0.00029563307,0.0002720829,0.00010796246,0.00006316769,0.00019530885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011315021,0.00026194155,0.00079429534,0.00009071435,0.0005200567,0.00007678158,0.00011903635,0.000116355324,0.00014519907],"category_scores_gemma":[0.00004558271,0.00020933224,0.0002831707,0.000082429426,0.00022730649,0.00002720353,0.000042089472,0.00041003487,0.000001264949],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8779975,0.0020740617,0.045666344,0.000011641514,0.00021095574,0.000001749299,0.00037629285,0.000055928696,0.07317035,0.000014592998,0.000089006564,0.00033155596],"study_design_scores_gemma":[0.85095644,0.0028587193,0.14369969,0.00005587052,0.00008361378,0.0000204305,0.00014062834,0.00025868247,0.0015049317,0.000015065529,0.00014729094,0.00025863477],"about_ca_topic_score_codex":0.000041443203,"about_ca_topic_score_gemma":0.000043628403,"teacher_disagreement_score":0.09803335,"about_ca_system_score_codex":0.000030925414,"about_ca_system_score_gemma":0.00011212468,"threshold_uncertainty_score":0.8536321},"labels":[],"label_agreement":null},{"id":"W4281294196","doi":"10.1177/20552173221102067","title":"Attitudes toward coronavirus disease 2019 vaccination in people with multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Vaccination; Medicine; Influenza vaccine; Multiple sclerosis; Adverse effect; Logistic regression; Population; Disease; Coronavirus disease 2019 (COVID-19); Demography; Environmental health; Immunology; Internal medicine; Infectious disease (medical specialty)","score_opus":0.21049615459634044,"score_gpt":0.4106501778545134,"score_spread":0.20015402325817297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281294196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937843,0.0033614736,0.00020627785,0.0016145356,0.00021086427,0.00061033823,0.00010232589,0.000036877624,0.000072995164],"genre_scores_gemma":[0.9941411,0.00013905825,0.0006949489,0.0045522028,0.00022962321,0.0001372925,0.000047739042,0.00004143591,0.00001657235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968093,0.0002951512,0.00081784657,0.0005284407,0.0011417845,0.00040746835],"domain_scores_gemma":[0.9987001,0.0005940631,0.00015534605,0.000181547,0.00011057954,0.0002583813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082083535,0.00026405606,0.00046768787,0.00022573967,0.0005236484,0.000101457874,0.00019948023,0.00008715808,0.0003164376],"category_scores_gemma":[0.000107560605,0.00022624871,0.0002795976,0.00035390278,0.00013612211,0.00033408598,0.000105985935,0.0008931746,0.000016092179],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072835525,0.002897766,0.96074414,0.000026605367,0.00011702501,0.000048862297,0.0006200144,0.00008002013,0.019900462,0.00004742154,0.00006944796,0.008164704],"study_design_scores_gemma":[0.014723658,0.0010893155,0.9744417,0.000117926786,0.00005687058,0.00007979436,0.00065805047,0.004026234,0.0029134986,0.00005280807,0.0015663808,0.00027374388],"about_ca_topic_score_codex":0.00021184284,"about_ca_topic_score_gemma":0.00017577375,"teacher_disagreement_score":0.016986962,"about_ca_system_score_codex":0.00024188499,"about_ca_system_score_gemma":0.00033690687,"threshold_uncertainty_score":0.9226154},"labels":[],"label_agreement":null},{"id":"W4282969109","doi":"10.1177/20552173221104918","title":"Peripartum disease activity in moderately and severely disabled women with multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto; St. Michael's Hospital","funders":"Barts Charity","keywords":"Multiple sclerosis; Disease; Medicine; Physical medicine and rehabilitation; Physical therapy; Gerontology; Psychology; Internal medicine; Psychiatry","score_opus":0.16134619391204033,"score_gpt":0.35036787254433577,"score_spread":0.18902167863229544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282969109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932712,0.0012710922,0.00011543105,0.0040528676,0.00012909385,0.0008362176,0.00019745737,0.00004268258,0.00008396203],"genre_scores_gemma":[0.99609315,0.0014815615,0.0012233082,0.00045553586,0.00018707306,0.0004001746,0.000029027236,0.000056139997,0.00007399753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959007,0.00056362344,0.00083462877,0.0007764516,0.0011999169,0.0007246693],"domain_scores_gemma":[0.99747,0.0009053658,0.00019015618,0.0002298969,0.00010732303,0.0010972327],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011270309,0.0004110599,0.00078762154,0.00020809355,0.0011881659,0.00016178595,0.00016542317,0.00009184544,0.00044900388],"category_scores_gemma":[0.00023369906,0.0003401861,0.0001951167,0.0003135577,0.0006252154,0.00048444545,0.00023490358,0.0012191884,0.0000037303548],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050768286,0.005259057,0.90032685,0.00007864909,0.00047121497,0.000089217836,0.0028056295,0.00073715835,0.025516542,0.000045058227,0.0001715253,0.0137308035],"study_design_scores_gemma":[0.019357191,0.0017079941,0.95136255,0.00018475513,0.000051340958,0.000068955655,0.0019499895,0.02397044,0.00056853174,0.000077636374,0.00031043557,0.00039019927],"about_ca_topic_score_codex":0.00007825986,"about_ca_topic_score_gemma":0.00006733103,"teacher_disagreement_score":0.051035672,"about_ca_system_score_codex":0.0003104228,"about_ca_system_score_gemma":0.00024729516,"threshold_uncertainty_score":0.999905},"labels":[],"label_agreement":null},{"id":"W4284675099","doi":"10.1177/20552173221111761","title":"Assessing proprioceptive acuity in people with multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Balance, Gait, and Falls Prevention","field":"Health Professions","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Multiple Sclerosis Society of Canada; University of Ottawa","keywords":"Proprioception; Multiple sclerosis; Physical medicine and rehabilitation; Psychology; Audiology; Medicine; Psychiatry","score_opus":0.18543735322393964,"score_gpt":0.41599452518680363,"score_spread":0.230557171962864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4284675099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99574655,0.00066395605,0.0006581583,0.0010601346,0.000609653,0.0007928342,0.00008205658,0.000047285375,0.0003393948],"genre_scores_gemma":[0.9957951,0.00024291802,0.0025968123,0.00053523685,0.00037434546,0.00024412766,0.0000820768,0.000040499315,0.00008890135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99542993,0.0014627661,0.0012981977,0.0005250269,0.00073479634,0.00054926955],"domain_scores_gemma":[0.99787587,0.001096365,0.00047059238,0.00015774572,0.000110569614,0.000288869],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0019882084,0.00027314795,0.00052619725,0.00014182222,0.00241,0.000084406216,0.0002242253,0.00017741426,0.00035921688],"category_scores_gemma":[0.00009059788,0.00023198318,0.00022513607,0.00033672003,0.00018845683,0.00073454616,0.00013823036,0.0019500211,0.000017486967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010906208,0.002790151,0.9634861,0.000024103401,0.00008689781,0.000007049805,0.0039560893,0.000050269322,0.022957293,0.00012397046,0.00015225407,0.0052752076],"study_design_scores_gemma":[0.010930393,0.0004656629,0.9709573,0.00028344878,0.000032690736,0.000020820586,0.013264358,0.003122543,0.000049560986,0.00021290407,0.00036760615,0.00029276154],"about_ca_topic_score_codex":0.00020574793,"about_ca_topic_score_gemma":0.00051784725,"teacher_disagreement_score":0.022907732,"about_ca_system_score_codex":0.00025399288,"about_ca_system_score_gemma":0.00030387446,"threshold_uncertainty_score":0.99888873},"labels":[],"label_agreement":null},{"id":"W4306880421","doi":"10.1177/20552173221128170","title":"Autoimmune diseases and cancers overlapping with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A systematic review","year":2022,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Autoimmune Neurological Disorders and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Neuromyelitis optica; Autoantibody; Myelin oligodendrocyte glycoprotein; Immunology; Multiple sclerosis; Autoimmunity; Optic neuritis; Disease; Pathology; Antibody; Dermatology; Experimental autoimmune encephalomyelitis","score_opus":0.11078807318113018,"score_gpt":0.37206325246990163,"score_spread":0.2612751792887714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306880421","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024617224,0.993752,0.00001715966,0.00024295492,0.00014296047,0.002995858,0.0003101058,0.00005520475,0.000022034092],"genre_scores_gemma":[0.02244974,0.9756041,0.00008328524,0.00057596015,0.00007223397,0.00045998447,0.00061298907,0.000075808755,0.00006585262],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99528,0.000770077,0.0019861364,0.0007295529,0.0008322302,0.00040195088],"domain_scores_gemma":[0.99723595,0.00083028147,0.0009812946,0.0002809555,0.000053665193,0.0006178671],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043573556,0.0006882995,0.0035939554,0.00011741928,0.0006287835,0.0000993019,0.00015571289,0.00019000663,0.0004003311],"category_scores_gemma":[0.00032624704,0.00044620008,0.0011223495,0.00026885202,0.000305993,0.00016507875,0.000099183366,0.0009996351,0.000006360511],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005314211,0.011780701,0.012390469,0.82817775,0.01667082,0.0031172156,0.0002881113,0.000018274211,0.000038544465,0.00014579007,0.00015862157,0.1218995],"study_design_scores_gemma":[0.01593584,0.0036111092,0.051401775,0.8710514,0.027811272,0.0012974765,0.00015938353,0.0005609382,5.4976255e-7,0.000046383648,0.026612623,0.0015113044],"about_ca_topic_score_codex":0.000026856787,"about_ca_topic_score_gemma":0.0000020242844,"teacher_disagreement_score":0.120388195,"about_ca_system_score_codex":0.00021873887,"about_ca_system_score_gemma":0.0004865951,"threshold_uncertainty_score":0.99979895},"labels":[],"label_agreement":null},{"id":"W4306954832","doi":"10.1177/20552173221132170","title":"Quantitative spinal cord MRI and sexual dysfunction in multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Fractional anisotropy; Medicine; Multiple sclerosis; Anxiety; Magnetic resonance imaging; Depression (economics); Internal medicine; Diffusion MRI; Spinal cord; Mood; Physical therapy; Psychiatry; Radiology","score_opus":0.31429161236454284,"score_gpt":0.415623184933406,"score_spread":0.10133157256886316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306954832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896238,0.00441682,0.00040859298,0.0041104057,0.0004255869,0.0007598618,0.00012335811,0.00004247991,0.000089101784],"genre_scores_gemma":[0.9915827,0.0018871512,0.0054792264,0.00044316793,0.0002973581,0.00014990098,0.00005629477,0.000045165307,0.000059025984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99560696,0.00060693244,0.0012877506,0.000755482,0.0011820563,0.0005608071],"domain_scores_gemma":[0.9977721,0.0011181484,0.0002490137,0.00018452265,0.00014663246,0.0005295879],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016559674,0.00036954347,0.0007403182,0.00033745836,0.0012236374,0.000115001996,0.0001589996,0.0001332779,0.00043339515],"category_scores_gemma":[0.00043835712,0.00034166477,0.00025292693,0.0003783615,0.0006605577,0.0003885415,0.00023776994,0.0014139996,0.000010147832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029694587,0.0035761227,0.7945226,0.00006176276,0.00046880625,0.00005475553,0.0014168002,0.0001977247,0.11404133,0.00020979602,0.0007871801,0.05496855],"study_design_scores_gemma":[0.017541813,0.00847476,0.9512699,0.00018739932,0.0000673471,0.00018168867,0.007503426,0.012609016,0.00085499196,0.00008580194,0.00085533946,0.00036849914],"about_ca_topic_score_codex":0.00018615091,"about_ca_topic_score_gemma":0.00012813458,"teacher_disagreement_score":0.15674734,"about_ca_system_score_codex":0.00020857446,"about_ca_system_score_gemma":0.00013551665,"threshold_uncertainty_score":0.99990356},"labels":[],"label_agreement":null},{"id":"W4309322144","doi":"10.1177/20552173221135888","title":"Satisfaction with alemtuzumab in relapsing multiple sclerosis patients: Results from the real-world PRO-ACT study","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Clinique Neuro-Outaouais","funders":"Sanofi","keywords":"Medicine; Multiple sclerosis; Observational study; Clinical endpoint; Adverse effect; Patient satisfaction; Quality of life (healthcare); Physical therapy; Internal medicine; Expanded Disability Status Scale; Clinical trial; Surgery; Psychiatry","score_opus":0.1904584400154137,"score_gpt":0.3710858660872564,"score_spread":0.1806274260718427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309322144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99378765,0.00048273287,0.000025643112,0.002666799,0.00038216604,0.0020476594,0.00039964565,0.000052209827,0.00015551106],"genre_scores_gemma":[0.996541,0.00075425283,0.0014375347,0.00031005652,0.00039288076,0.0002659613,0.00019253501,0.00006285394,0.000042876825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99359274,0.001216322,0.001810283,0.0008843261,0.0019243947,0.00057193334],"domain_scores_gemma":[0.9954307,0.0031268161,0.00046629645,0.00040072773,0.00020569707,0.0003697411],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0019941397,0.00042714432,0.0007480179,0.00023991015,0.0017231242,0.00017224808,0.00026440085,0.00008963531,0.00029489605],"category_scores_gemma":[0.00061026606,0.0002975629,0.0003079781,0.000616192,0.00040465273,0.00043411597,0.00022769738,0.00176494,0.0000070450915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013271573,0.0041835923,0.9596725,0.000005585397,0.00039963287,0.000018792309,0.0040689916,0.00028840743,0.0028517966,0.000005055302,0.00032485576,0.01490921],"study_design_scores_gemma":[0.039513096,0.0027331617,0.94686866,0.00030098256,0.00010598585,0.000010015052,0.0074224034,0.0022086233,0.00020462375,0.00001775785,0.0002926711,0.00032201875],"about_ca_topic_score_codex":0.0044890563,"about_ca_topic_score_gemma":0.0072999736,"teacher_disagreement_score":0.026241524,"about_ca_system_score_codex":0.00048658458,"about_ca_system_score_gemma":0.00020446857,"threshold_uncertainty_score":0.99994767},"labels":[],"label_agreement":null},{"id":"W4310598601","doi":"10.1177/20552173221138935","title":"Profiles of resilience in multiple sclerosis family care-partners: A Canadian cross-sectional study","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; University of Ottawa","funders":"","keywords":"Psychological resilience; Context (archaeology); Multilevel model; Psychology; Social support; Population; Multiple sclerosis; Expanded Disability Status Scale; Cross-sectional study; Clinical psychology; Medicine; Gerontology; Psychiatry; Social psychology; Environmental health; Geography","score_opus":0.26364523504316434,"score_gpt":0.42362612704434643,"score_spread":0.1599808920011821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310598601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946622,0.0025635941,0.000018210816,0.0003811792,0.00037735177,0.0014010594,0.00034204315,0.000024915806,0.00022942215],"genre_scores_gemma":[0.9977736,0.00035989165,0.0010169395,0.00018261054,0.0002452567,0.00027821586,0.00006714747,0.000041251587,0.000035078257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99424577,0.0007540168,0.0018420246,0.00075849605,0.0017342553,0.00066542736],"domain_scores_gemma":[0.9973057,0.0010675611,0.00028306755,0.00027609084,0.0003352149,0.00073236454],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002207756,0.00034668608,0.0007519343,0.0005529622,0.0012746874,0.00011275446,0.00034063426,0.00013809935,0.0004337346],"category_scores_gemma":[0.00059651537,0.0003261599,0.00042772447,0.0005455194,0.0007010343,0.00032093533,0.00019652922,0.0012473211,0.0000069174525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002153794,0.002616319,0.9631327,0.00002695417,0.00019325533,0.000030302805,0.0028979366,0.0006242424,0.02599486,0.000015472386,0.000083672676,0.0022305055],"study_design_scores_gemma":[0.0131644355,0.0019519594,0.9643531,0.00010762799,0.000032732965,0.000041364918,0.016647825,0.0020048916,0.0012099412,0.000013663538,0.00018894477,0.00028350344],"about_ca_topic_score_codex":0.0118357325,"about_ca_topic_score_gemma":0.009409284,"teacher_disagreement_score":0.024784919,"about_ca_system_score_codex":0.00049294526,"about_ca_system_score_gemma":0.0007276081,"threshold_uncertainty_score":0.99991906},"labels":[],"label_agreement":null},{"id":"W4311822595","doi":"10.1177/20552173221144226","title":"Assessing care-related regret among nurses specialized in multiple sclerosis: A psychometric analysis of a new assessment battery","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Roche España","keywords":"Regret; Reliability (semiconductor); Scale (ratio); Psychology; Multiple sclerosis; Clinical psychology; Applied psychology; Psychiatry; Statistics; Mathematics","score_opus":0.24620015966906691,"score_gpt":0.43635697319494043,"score_spread":0.19015681352587352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311822595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99238604,0.004395959,0.0002910712,0.00093483645,0.00060395873,0.0008943507,0.000133722,0.000040956267,0.0003190824],"genre_scores_gemma":[0.9932502,0.0013228523,0.004628692,0.00015498314,0.00025396366,0.000102752165,0.00017971515,0.000053207117,0.0000536317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9931879,0.0009424476,0.0025625592,0.0008484059,0.0018259351,0.0006327183],"domain_scores_gemma":[0.9964421,0.0016132703,0.00070085656,0.00035856312,0.0002380861,0.000647149],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017789623,0.0004514519,0.0016434211,0.0019574997,0.00077178504,0.00019240995,0.0003306899,0.00019494149,0.0014693062],"category_scores_gemma":[0.0005253916,0.00041474626,0.0011998797,0.0032146226,0.0005626612,0.00057266845,0.00019856727,0.001528303,0.000002439634],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013219138,0.002597024,0.9497511,0.000029622275,0.002387777,0.000016148948,0.0032342197,0.0013471518,0.018737096,0.000020068013,0.00022340455,0.020334478],"study_design_scores_gemma":[0.018734278,0.00078986,0.95262975,0.0003311495,0.000784313,0.000019738816,0.011170243,0.014406912,0.0005776969,0.000026121927,0.00016742316,0.00036254048],"about_ca_topic_score_codex":0.00043886044,"about_ca_topic_score_gemma":0.00018844138,"teacher_disagreement_score":0.019971939,"about_ca_system_score_codex":0.00046059466,"about_ca_system_score_gemma":0.0004089437,"threshold_uncertainty_score":0.9998304},"labels":[],"label_agreement":null},{"id":"W4313437367","doi":"10.1177/20552173221142741","title":"Endocrine and multiple sclerosis outcomes in patients with autoimmune thyroid events in the alemtuzumab CARE-MS studies","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Bayer HealthCare; Sanofi","keywords":"Medicine; Alemtuzumab; Multiple sclerosis; Thyroid; Endocrine disease; Adverse effect; Graves' disease; Internal medicine; Anti-thyroid autoantibodies; Pediatrics; Endocrine system; Immunology; Hormone; Autoantibody; Antibody","score_opus":0.1679481370235735,"score_gpt":0.3896133738312529,"score_spread":0.22166523680767938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313437367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99120307,0.0041303947,0.0000043832165,0.0031294385,0.00017972071,0.0012069918,0.000071147624,0.00004207361,0.0000327913],"genre_scores_gemma":[0.99359745,0.0052037956,0.00055231334,0.00027318287,0.00011890912,0.00011495559,0.00007406354,0.000041171294,0.000024189934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957783,0.0004592717,0.0012685673,0.0005965102,0.0012441428,0.000653205],"domain_scores_gemma":[0.9969175,0.0021880853,0.0001896972,0.00025710274,0.00020675134,0.00024088666],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010959799,0.00042320022,0.0009534905,0.00035643863,0.0005011642,0.00006569717,0.00022758133,0.0001180526,0.000026786285],"category_scores_gemma":[0.00066557684,0.00026036962,0.00024618045,0.0005235658,0.00056338153,0.00034869945,0.00016593584,0.00087193184,0.000010882193],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017590596,0.0013456076,0.9849593,0.00004844613,0.00036278463,0.000017754659,0.005044048,0.000052376567,0.0013447963,0.000010166242,0.000066483626,0.004989193],"study_design_scores_gemma":[0.028886968,0.0013010756,0.9602922,0.00055050955,0.000056209985,0.000011987072,0.007817101,0.00051478134,0.00019219679,0.000029990235,0.000074812975,0.000272162],"about_ca_topic_score_codex":0.00012679928,"about_ca_topic_score_gemma":0.00029458338,"teacher_disagreement_score":0.027127909,"about_ca_system_score_codex":0.00014468817,"about_ca_system_score_gemma":0.000073743395,"threshold_uncertainty_score":0.99998486},"labels":[],"label_agreement":null},{"id":"W4313648494","doi":"10.1177/20552173221143398","title":"Lower corticospinal excitability and greater fatigue among people with multiple sclerosis experiencing pain","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Canadian Institutes of Health Research; Canada Research Chairs; Canada Foundation for Innovation","keywords":"Transcranial magnetic stimulation; Physical medicine and rehabilitation; Physical therapy; Mood; Medicine; Neuromodulation; Visual analogue scale; Quality of life (healthcare); Psychology; Stimulation; Psychiatry; Internal medicine","score_opus":0.18964242464001752,"score_gpt":0.3643150694069121,"score_spread":0.1746726447668946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313648494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99530536,0.0006562092,0.0009904018,0.0016708138,0.00023570927,0.0008921586,0.00005044702,0.00014033799,0.000058550304],"genre_scores_gemma":[0.99528253,0.0010936183,0.0026280382,0.0002551607,0.0004063094,0.00017448366,0.000044474313,0.000068914625,0.000046467736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99525875,0.00050833914,0.0012845015,0.00091635756,0.0012172873,0.00081476977],"domain_scores_gemma":[0.99645984,0.0017329801,0.00023896557,0.0003163233,0.00028676027,0.0009651017],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021592616,0.0005051118,0.0009114742,0.00023770059,0.0009973693,0.00023490697,0.00016994504,0.00023128866,0.00028779844],"category_scores_gemma":[0.00091540616,0.00037949192,0.00036653876,0.00049903407,0.001157591,0.0005561904,0.00015385954,0.00083210797,0.0000149554535],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023365961,0.0007550277,0.9624553,0.00006114277,0.00032611715,0.00003564217,0.0031446745,0.000042210697,0.020922534,0.000008310223,0.00011911633,0.0097933505],"study_design_scores_gemma":[0.009588155,0.0017924423,0.9674218,0.0005904452,0.00008356523,0.000067291185,0.0044005066,0.0141624315,0.0013568548,0.000020609623,0.00008503127,0.0004308348],"about_ca_topic_score_codex":0.00016203393,"about_ca_topic_score_gemma":0.00022345496,"teacher_disagreement_score":0.019565681,"about_ca_system_score_codex":0.00010388123,"about_ca_system_score_gemma":0.00011187356,"threshold_uncertainty_score":0.9998657},"labels":[],"label_agreement":null},{"id":"W4366263061","doi":"10.1177/20552173231167079","title":"Severity and worsening of fatigue among individuals with multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Janssen Research and Development","keywords":"Multiple sclerosis; Medicine; Depression (economics); Quality of life (healthcare); Physical therapy; Disease; Longitudinal study; Expanded Disability Status Scale; Chronic fatigue; Chronic fatigue syndrome; Psychiatry; Internal medicine; Pathology","score_opus":0.23898257523234614,"score_gpt":0.3865833825828719,"score_spread":0.14760080735052575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366263061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966568,0.0009163191,0.00021403696,0.0011862465,0.00011922211,0.00060995674,0.00011480636,0.00007584274,0.00010677936],"genre_scores_gemma":[0.9905533,0.0024737888,0.0064311684,0.00010000911,0.0002514536,0.00004821361,0.00005304235,0.00004730192,0.000041704992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99631476,0.00026866727,0.0011775572,0.00057031336,0.0011346723,0.000534025],"domain_scores_gemma":[0.9969748,0.0016418556,0.00031298026,0.00020810078,0.00023139882,0.000630842],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001346886,0.00035823276,0.0008499056,0.00029248468,0.00057413965,0.00008209409,0.00014793387,0.00020448383,0.00010742979],"category_scores_gemma":[0.00051957346,0.00027583,0.0002889505,0.00049234094,0.001198891,0.0004122589,0.00014724954,0.0007394506,0.0000066350813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092695444,0.00055898924,0.96265495,0.00005955065,0.0005253164,0.000012265573,0.001291497,0.000049125923,0.024332497,0.000020122343,0.00016711304,0.009401623],"study_design_scores_gemma":[0.010127993,0.00074393157,0.97382134,0.0008521352,0.00010635851,0.0000466579,0.001942287,0.0046732007,0.007246318,0.000035257788,0.000118555974,0.00028595043],"about_ca_topic_score_codex":0.00009021707,"about_ca_topic_score_gemma":0.00006253855,"teacher_disagreement_score":0.017086178,"about_ca_system_score_codex":0.000039018418,"about_ca_system_score_gemma":0.000094868956,"threshold_uncertainty_score":0.99996936},"labels":[],"label_agreement":null},{"id":"W4384831665","doi":"10.1177/20552173231188469","title":"Pain and participation in social activities in people with relapsing remitting and progressive multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University; St. Michael's Hospital; University of Calgary; University of Manitoba","funders":"Canadian Institutes of Health Research; Institute of Musculoskeletal Health and Arthritis; Takeda Canada; Pfizer Canada; Sandoz Canada; Crohn's and Colitis Canada; Arthritis Society; Royal College of Physicians and Surgeons of Canada; Research Nova Scotia; Multiple Sclerosis Society; Research Manitoba; Mylan; Biogen; Janssen Canada; Amgen Canada; U.S. Department of Defense; Government of Alberta; AbbVie Canada; Multiple Sclerosis Society of Canada; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Multiple sclerosis; Relapsing remitting; Physical therapy; Medicine; McGill Pain Questionnaire; Expanded Disability Status Scale; Mood; Psychology; Clinical psychology; Visual analogue scale; Psychiatry","score_opus":0.17894582698084197,"score_gpt":0.4016830283170976,"score_spread":0.22273720133625566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384831665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953299,0.0013831684,0.000058174413,0.0024752205,0.000057898887,0.0005994138,0.000018320174,0.000042825213,0.000035061155],"genre_scores_gemma":[0.9962645,0.0014923126,0.0016799853,0.00012381881,0.00024523016,0.000120284436,0.000025538953,0.00003501636,0.000013294953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969831,0.0005298466,0.00086719193,0.0005041783,0.0006000701,0.0005155975],"domain_scores_gemma":[0.99719214,0.0021929774,0.00018646548,0.00008266795,0.0000741724,0.00027158263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002164317,0.00026709144,0.0006054723,0.00031581632,0.0005672796,0.00013646261,0.00005936407,0.00016822541,0.00002250018],"category_scores_gemma":[0.0007555248,0.000221938,0.00010137422,0.0004619396,0.000513534,0.00043618266,0.00008376955,0.00070172135,0.0000013652462],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001556769,0.00052673015,0.93883926,0.000058594436,0.000090302514,0.000019394298,0.0059392545,0.000029619323,0.01678192,0.000015913774,0.000033736527,0.036108494],"study_design_scores_gemma":[0.010216791,0.0006219382,0.96351576,0.00102417,0.000029397275,0.000025333084,0.0065425886,0.016950171,0.00078033295,0.000046078894,0.00001800208,0.00022946343],"about_ca_topic_score_codex":0.000084667685,"about_ca_topic_score_gemma":0.00043512063,"teacher_disagreement_score":0.03587903,"about_ca_system_score_codex":0.00008869818,"about_ca_system_score_gemma":0.00007648023,"threshold_uncertainty_score":0.9050369},"labels":[],"label_agreement":null},{"id":"W4386172465","doi":"10.1177/20552173231194352","title":"Sleep disturbance and fatigue in multiple sclerosis: A systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Medical Rehabilitation Research; National Institute on Minority Health and Health Disparities; Multiple Sclerosis Society; National Multiple Sclerosis Society","keywords":"Insomnia; Sleep (system call); Sleep disorder; Meta-analysis; Sleep onset; Sleep onset latency; Physical therapy; Medicine; Actigraphy; Psychology; Clinical psychology; Psychiatry; Internal medicine","score_opus":0.5840726062392975,"score_gpt":0.47160494252181306,"score_spread":0.1124676637174844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386172465","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034742412,0.9935366,0.00005954794,0.0010602021,0.00008193272,0.0043675,0.00047490766,0.000056846206,0.000015069413],"genre_scores_gemma":[0.019775527,0.9772977,0.00087085925,0.00035896176,0.00014831191,0.0011873705,0.00015328881,0.000110288536,0.00009765109],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99063545,0.0015709559,0.0044366643,0.0013720474,0.0012712616,0.00071359484],"domain_scores_gemma":[0.99266034,0.0046522785,0.0010787699,0.00053462613,0.00021009718,0.00086386496],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003317218,0.0010768635,0.011710677,0.0007183936,0.0005104154,0.00025414463,0.00032350974,0.0004903799,0.00014006675],"category_scores_gemma":[0.0017685492,0.00072054414,0.0036547976,0.0012403497,0.00076014816,0.0003259,0.00026855659,0.0016940767,0.000018567187],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002954521,0.0021376293,0.0065703033,0.6588356,0.3135624,0.00011270204,0.00073589577,0.000007498139,0.000025657002,0.00005459702,0.00024277107,0.01741952],"study_design_scores_gemma":[0.006981421,0.00062447065,0.029597558,0.16325304,0.7938425,0.00028363985,0.0004226987,0.0013483112,0.000004322447,0.000031730153,0.001988536,0.0016217765],"about_ca_topic_score_codex":0.00007262459,"about_ca_topic_score_gemma":0.00014692343,"teacher_disagreement_score":0.49558255,"about_ca_system_score_codex":0.00013770847,"about_ca_system_score_gemma":0.00012188601,"threshold_uncertainty_score":0.9995246},"labels":[],"label_agreement":null},{"id":"W4386192718","doi":"10.1177/20552173231195879","title":"Functional connectome fingerprinting and stability in multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Functional Brain Connectivity Studies","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Chugai Pharmaceutical; Humboldt-Universität zu Berlin; National Multiple Sclerosis Society; Deutsche Forschungsgemeinschaft; Alexion Pharmaceuticals; Teva Pharmaceutical Industries; Berlin Institute of Health; Biogen; Bayer; Arthur Arnstein Stiftung; Guthy-Jackson Charitable Foundation; Sanofi","keywords":"Connectome; Human Connectome Project; Resting state fMRI; Neuroscience; Multiple sclerosis; Default mode network; Cognition; Psychology; Functional connectivity; Identification (biology); Biology; Psychiatry","score_opus":0.35284724191698325,"score_gpt":0.34360571576774157,"score_spread":0.009241526149241674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386192718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99282247,0.00037413958,0.00017245072,0.005402887,0.00068210607,0.0002868275,0.00006361988,0.00010169426,0.00009383336],"genre_scores_gemma":[0.9978061,0.0004916372,0.00040296462,0.00088930095,0.00031073406,0.00004328123,0.000008999276,0.000028103565,0.00001892611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99670583,0.0004501475,0.0009344075,0.00083406176,0.0006279885,0.0004475496],"domain_scores_gemma":[0.98407537,0.015296549,0.00017074142,0.00013819976,0.0000663685,0.00025278504],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015765147,0.00028229426,0.0004267054,0.00022292986,0.00087738194,0.00016717878,0.00013889292,0.00014526301,0.00018987404],"category_scores_gemma":[0.0054402906,0.00026666676,0.00021663816,0.0004769424,0.00060575973,0.0005569717,0.00015792024,0.0006432473,0.000042563555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071803795,0.00064531114,0.6204849,0.000017427168,0.000044269425,0.000012839299,0.00078596926,0.00020285948,0.37058547,0.0005450205,0.00027196415,0.0056859436],"study_design_scores_gemma":[0.0048488504,0.00020896624,0.9467013,0.00010470322,0.000011890322,0.000045190656,0.000887907,0.00981553,0.035780285,0.0010601558,0.0002195188,0.0003156931],"about_ca_topic_score_codex":0.000034728873,"about_ca_topic_score_gemma":0.0000804888,"teacher_disagreement_score":0.3348052,"about_ca_system_score_codex":0.000069445334,"about_ca_system_score_gemma":0.000059069163,"threshold_uncertainty_score":0.99997854},"labels":[],"label_agreement":null},{"id":"W4387477724","doi":"10.1177/20552173231203816","title":"Tolerability of subcutaneous ofatumumab with long-term exposure in relapsing multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Novartis Pharma","keywords":"Tolerability; Ofatumumab; Medicine; Teriflunomide; Adverse effect; Population; Incidence (geometry); Internal medicine; Multiple sclerosis; Rituximab; Fingolimod; Immunology; Environmental health","score_opus":0.18578832728008232,"score_gpt":0.37441799480282256,"score_spread":0.18862966752274024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387477724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954643,0.0018969929,0.00012707559,0.0012357825,0.0002239343,0.0008038951,0.00007413925,0.00007546278,0.00009837304],"genre_scores_gemma":[0.994182,0.0031767844,0.0021017923,0.00008511225,0.00023985477,0.000050679926,0.00006417122,0.000057476762,0.00004215697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952272,0.00037641064,0.00176894,0.0007074459,0.0012500666,0.0006699099],"domain_scores_gemma":[0.99675363,0.0017881547,0.00032159238,0.00033322527,0.00028340897,0.00051997503],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014000173,0.00040827287,0.001068359,0.00036175767,0.00037564107,0.00007891287,0.00021364448,0.0002560005,0.0001938358],"category_scores_gemma":[0.00054191094,0.00032256043,0.00044504667,0.00068405934,0.0008517824,0.0003358692,0.00011408028,0.0010116069,0.000015930522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005561001,0.0017500564,0.89668614,0.00009919185,0.000281222,0.000111907095,0.0010501806,0.00013190639,0.07968673,0.0000112332345,0.000048811977,0.014581612],"study_design_scores_gemma":[0.015267949,0.0020215798,0.97085685,0.0014003349,0.000071091796,0.00018945141,0.00086493033,0.0023692918,0.006593841,0.000030304727,0.000017119819,0.00031726994],"about_ca_topic_score_codex":0.00007067443,"about_ca_topic_score_gemma":0.00022565314,"teacher_disagreement_score":0.07417069,"about_ca_system_score_codex":0.00013521349,"about_ca_system_score_gemma":0.00018046478,"threshold_uncertainty_score":0.99992263},"labels":[],"label_agreement":null},{"id":"W4393989530","doi":"10.1177/20552173241238627","title":"Subclinical atherosclerosis in multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Multiple Sclerosis Society of Canada; European Genomic Institute for Diabetes","keywords":"Medicine; Subclinical infection; Multiple sclerosis; Internal medicine; Logistic regression; Framingham Risk Score; Cardiology; Odds ratio; Disease; Immunology","score_opus":0.2987553641126069,"score_gpt":0.4099666718416961,"score_spread":0.11121130772908921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393989530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804724,0.010149202,0.00043864947,0.006358248,0.0010231346,0.0008978361,0.00011402177,0.00018391357,0.00036263053],"genre_scores_gemma":[0.9819027,0.011588634,0.0043547335,0.0005612019,0.0011906811,0.0001103245,0.000049075705,0.00011004832,0.00013258611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9936361,0.000506697,0.0023640501,0.001171046,0.0013755864,0.00094652636],"domain_scores_gemma":[0.99488664,0.003390539,0.00016793293,0.00036241676,0.00019117471,0.0010013061],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024016874,0.0006047803,0.0011770494,0.00048756966,0.0005406973,0.00043047025,0.00030308974,0.00046619383,0.00064833194],"category_scores_gemma":[0.0009933684,0.000498966,0.0010461855,0.0006673093,0.000981342,0.00066811393,0.00017576235,0.00203612,0.00015108862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023483073,0.0035148596,0.83197826,0.00014929674,0.00075341697,0.000096503776,0.0013099218,0.000044649245,0.09999002,0.00030490218,0.0014257642,0.058084108],"study_design_scores_gemma":[0.011779121,0.0010912627,0.96166456,0.0019593097,0.00012682907,0.00013569376,0.0007556018,0.015200364,0.003945104,0.00018180208,0.0025980556,0.0005623095],"about_ca_topic_score_codex":0.000102979946,"about_ca_topic_score_gemma":0.00011962911,"teacher_disagreement_score":0.1296863,"about_ca_system_score_codex":0.00023234612,"about_ca_system_score_gemma":0.00027944308,"threshold_uncertainty_score":0.9997462},"labels":[],"label_agreement":null},{"id":"W4399018288","doi":"10.1177/20552173241247182","title":"Comparative effectiveness of dimethyl fumarate versus non-specific immunosuppressants: Real-world evidence from MSBase","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches","funders":"EMD Serono; National Research Foundation; Sanofi; European Commission; Biogen; Celgene; Alnylam Pharmaceuticals; International Progressive MS Alliance; Sanofi Genzyme; F. Hoffmann-La Roche; Monash University; Alexion Pharmaceuticals; Teva Pharmaceutical Industries; Universität Basel; Bristol-Myers Squibb","keywords":"Dimethyl fumarate; Chemistry; Pharmacology; Medicine; Immunology; Multiple sclerosis","score_opus":0.31401003087453827,"score_gpt":0.458550022342783,"score_spread":0.14453999146824476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399018288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9716507,0.02519143,0.00055595825,0.00038520107,0.0010371886,0.0006594448,0.00019378895,0.00005919645,0.00026705972],"genre_scores_gemma":[0.98172,0.015030111,0.0025434394,0.000017252572,0.00051497447,0.000054277974,0.000054403044,0.000042009025,0.000023586717],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9960748,0.0007552409,0.0012192149,0.0006416073,0.00094069145,0.00036842946],"domain_scores_gemma":[0.9886521,0.010292137,0.00016728167,0.00024998016,0.00025063893,0.00038784373],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015744128,0.00035502782,0.0010305933,0.00022683835,0.00029967795,0.00014680745,0.00019830081,0.00013655738,0.0003287157],"category_scores_gemma":[0.00020209767,0.00027728983,0.0005608629,0.00037091825,0.00080186094,0.0005414399,0.000102430204,0.00088445295,0.000041104708],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028568877,0.0016372326,0.08357451,0.00022505039,0.0023593984,0.00006216765,0.0022153156,0.00009226288,0.8698228,0.00010118098,0.00054545427,0.010795755],"study_design_scores_gemma":[0.009315225,0.0012059859,0.8605551,0.004364622,0.00015383857,0.000008801067,0.0005942915,0.0036450895,0.11957167,0.00007279766,0.00024703736,0.0002655253],"about_ca_topic_score_codex":0.000292882,"about_ca_topic_score_gemma":0.000045480087,"teacher_disagreement_score":0.7769806,"about_ca_system_score_codex":0.00013708847,"about_ca_system_score_gemma":0.00015438496,"threshold_uncertainty_score":0.99996793},"labels":[],"label_agreement":null},{"id":"W4403215541","doi":"10.1177/20552173241285546","title":"Cesarian sections in women with multiple sclerosis: A Canadian prospective pregnancy study","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital; University of Alberta; University of British Columbia","funders":"Multiple Sclerosis Society of Canada; Biogen","keywords":"Pregnancy; Multiple sclerosis; Obstetrics; Prospective cohort study; Medicine; Psychiatry; Surgery; Biology","score_opus":0.13388811882265836,"score_gpt":0.36428925077724045,"score_spread":0.2304011319545821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403215541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902315,0.0045944415,0.000084035004,0.002173822,0.00034346993,0.0019452017,0.000111082125,0.00009094216,0.0004255074],"genre_scores_gemma":[0.99660885,0.0011355251,0.0009177151,0.00015248767,0.00044975683,0.00055688457,0.000014499345,0.000070492846,0.000093795774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99592465,0.00032012185,0.0011040454,0.00087261986,0.0009161384,0.00086240965],"domain_scores_gemma":[0.9976125,0.00070975866,0.0000936854,0.00023969989,0.00019880467,0.0011455816],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00095541123,0.0004335277,0.0007191444,0.000587496,0.00070157787,0.00035664768,0.00017652799,0.00018798203,0.00027738055],"category_scores_gemma":[0.00025299678,0.0003326566,0.00022198996,0.0007195389,0.00042887434,0.0005633467,0.00005847489,0.0013699114,0.000028968956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025735463,0.003408421,0.95362943,0.000065271546,0.0010338826,0.00022830075,0.015507111,0.00006931713,0.003750459,0.00003990397,0.00013567363,0.019558702],"study_design_scores_gemma":[0.012484023,0.0035071108,0.96431184,0.0021148648,0.00008229873,0.00011958491,0.013617781,0.0026925853,0.00036282386,0.00005809441,0.0002792121,0.00036976955],"about_ca_topic_score_codex":0.0053353603,"about_ca_topic_score_gemma":0.0428138,"teacher_disagreement_score":0.03747844,"about_ca_system_score_codex":0.00068002107,"about_ca_system_score_gemma":0.00070164533,"threshold_uncertainty_score":0.99991256},"labels":[],"label_agreement":null},{"id":"W4405090465","doi":"10.1177/20552173241301030","title":"Heterogeneity of aerobic fitness changes with exercise training in progressive multiple sclerosis: Secondary, exploratory analysis of data from the CogEx trial","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; European Genomic Institute for Diabetes","keywords":"Aerobic exercise; Multiple sclerosis; Physical medicine and rehabilitation; Psychology; Exploratory analysis; Physical therapy; Medicine; Gerontology; Data science; Computer science; Psychiatry","score_opus":0.3900389121474257,"score_gpt":0.42241183084893635,"score_spread":0.032372918701510656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405090465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97456294,0.021514721,0.00017418302,0.001181409,0.00023298924,0.0011387669,0.0011542856,0.000027879552,0.000012833293],"genre_scores_gemma":[0.9934415,0.0036052626,0.0019038431,0.00007543888,0.00037880577,0.00013842604,0.0004116441,0.00004103328,0.00000403942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99578416,0.00048330764,0.0013997271,0.0008043606,0.0011168716,0.0004115874],"domain_scores_gemma":[0.9957052,0.0028731788,0.00037458082,0.0005376991,0.0002140406,0.0002952937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018633235,0.0003680251,0.0013460306,0.00036689953,0.00023618308,0.00011175156,0.00048215562,0.00018607659,0.00024291058],"category_scores_gemma":[0.00030057743,0.00023692394,0.0004541229,0.0009040134,0.001058531,0.0005119973,0.00020897081,0.0008387969,0.0000018968957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10419785,0.0063726883,0.53255343,0.00039740556,0.019953946,0.00012636768,0.0275602,0.00040535216,0.1119292,0.0000364738,0.0004963085,0.19597074],"study_design_scores_gemma":[0.0651459,0.0021124673,0.8725644,0.004515891,0.002534231,0.000016513966,0.011093119,0.025364315,0.015945565,0.00002230143,0.00020112003,0.00048418902],"about_ca_topic_score_codex":0.00011791429,"about_ca_topic_score_gemma":0.0013890404,"teacher_disagreement_score":0.3400109,"about_ca_system_score_codex":0.000052668205,"about_ca_system_score_gemma":0.00038307876,"threshold_uncertainty_score":0.9661478},"labels":[],"label_agreement":null},{"id":"W4407040978","doi":"10.1177/20552173251315161","title":"Disproportional smaller fornix with altered microstructure in pediatric multiple sclerosis shown by high-resolution fluid-suppressed diffusion tractography","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Fornix; Diffusion MRI; Fractional anisotropy; White matter; Tractography; Hippocampus; Medicine; Nuclear medicine; Neuroscience; Psychology; Internal medicine; Magnetic resonance imaging; Radiology","score_opus":0.06604719742723783,"score_gpt":0.32421021881174383,"score_spread":0.258163021384506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407040978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98891115,0.004247686,0.0014601108,0.0033517615,0.00041584278,0.0011454095,0.0003262049,0.000059889073,0.00008196754],"genre_scores_gemma":[0.98908633,0.0048834523,0.004477106,0.00041042644,0.00051645294,0.00012661378,0.00037060698,0.000052395175,0.00007661127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951189,0.0003270723,0.0016970383,0.0009314773,0.0011742988,0.0007512067],"domain_scores_gemma":[0.9976096,0.00094689004,0.0003241319,0.0002877693,0.00028812067,0.0005434745],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00073894125,0.00056625804,0.0009308178,0.0005144474,0.0007310342,0.00018245877,0.0002567211,0.00039286722,0.00036164024],"category_scores_gemma":[0.00028230442,0.00043236755,0.00050136074,0.00067518104,0.0006206127,0.00044838103,0.00011603996,0.0012501015,0.000005654416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005618088,0.002692357,0.7670094,0.00007858761,0.00031996434,0.000009287927,0.00026759607,0.00009886826,0.21702757,0.000033049957,0.001994906,0.004850349],"study_design_scores_gemma":[0.024163842,0.0007442283,0.9627295,0.00048703497,0.00016442205,0.000027997728,0.00037707307,0.0037185377,0.0066465484,0.000059761296,0.00046077144,0.0004202866],"about_ca_topic_score_codex":0.00017493892,"about_ca_topic_score_gemma":0.00021760998,"teacher_disagreement_score":0.21038103,"about_ca_system_score_codex":0.0001510471,"about_ca_system_score_gemma":0.00020438673,"threshold_uncertainty_score":0.99981284},"labels":[],"label_agreement":null},{"id":"W4408523255","doi":"10.1177/20552173251321814","title":"Characterizing the diversity of the multiple sclerosis population in Canada: A scoping review","year":2025,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; University of British Columbia; St. Michael's Hospital; University of Waterloo; Queen's University; University of Manitoba; University of Toronto; Dalhousie University","funders":"Multiple Sclerosis Society of Canada","keywords":"CINAHL; MEDLINE; Medicine; Scopus; Population; Family medicine; Health care; Gerontology; Nursing; Environmental health; Psychological intervention","score_opus":0.3078140036118556,"score_gpt":0.41723195738932256,"score_spread":0.10941795377746694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408523255","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00830601,0.9862968,0.000005801447,0.0015841122,0.00049386366,0.0030834128,0.00018733952,0.000009598057,0.00003308164],"genre_scores_gemma":[0.14358874,0.85545516,0.00012258936,0.0004456753,0.00019356316,0.000097712014,0.000057281537,0.00002555382,0.000013743565],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9939737,0.0011044204,0.0026427782,0.00055804936,0.001266137,0.00045491455],"domain_scores_gemma":[0.9948201,0.0033956289,0.0009602626,0.00041617022,0.00017217085,0.0002356248],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016966227,0.0004984477,0.0025442704,0.00015092963,0.0009073496,0.000047703226,0.0005379181,0.00021862851,0.00008216791],"category_scores_gemma":[0.0014415104,0.00028785,0.0012289403,0.0005964175,0.00032677883,0.00017493966,0.00061572366,0.0014782388,0.0000014796688],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033629153,0.0008470238,0.30904543,0.051601525,0.001040824,0.000010261037,0.00032807133,0.000005703646,0.00012604007,0.000014547664,0.00036429684,0.63628],"study_design_scores_gemma":[0.0024561367,0.00007385519,0.48301688,0.5110712,0.0006937833,0.000029217987,0.0001486087,0.00008990362,0.000026264284,0.0000036218153,0.0020950418,0.00029547044],"about_ca_topic_score_codex":0.053157665,"about_ca_topic_score_gemma":0.10810886,"teacher_disagreement_score":0.6359845,"about_ca_system_score_codex":0.0005799708,"about_ca_system_score_gemma":0.0020564713,"threshold_uncertainty_score":0.9999574},"labels":[],"label_agreement":null},{"id":"W4412016986","doi":"10.1177/20552173251355677","title":"Delphi panel to understand the real-world occurrence and management of ofatumumab injection-related reactions among healthcare providers of people with relapsing multiple sclerosis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"Novartis Pharmaceuticals Corporation","keywords":"Ofatumumab; Medicine; Delphi method; Delphi; Clinical Practice; Health care; Family medicine; Physical therapy; Demographics; Internal medicine; CD20","score_opus":0.1938430667576781,"score_gpt":0.38737886802890953,"score_spread":0.19353580127123143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412016986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99036735,0.0013979365,0.00071204157,0.0055779084,0.00019740644,0.0013925007,0.000085447544,0.000028322469,0.00024109303],"genre_scores_gemma":[0.9922588,0.004631065,0.0028020267,0.00010167528,0.00003726037,0.000054726894,0.000020465095,0.000019382043,0.00007463457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968103,0.00026117085,0.0013530437,0.00048565166,0.0007393888,0.00035040014],"domain_scores_gemma":[0.9975519,0.0011871589,0.00036445033,0.0002585397,0.00032023684,0.00031771153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088997424,0.00027726637,0.0006364216,0.0003132322,0.0006990809,0.00006388102,0.00014926295,0.00011520182,0.000029205254],"category_scores_gemma":[0.00016457237,0.00019623167,0.00021891868,0.0008124902,0.0008401181,0.00025057714,0.00010895682,0.0006183915,7.5031926e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003793082,0.0011963521,0.96377355,0.00049606105,0.0014189823,0.0000041568264,0.0052026235,0.0004165151,0.0101568885,0.0006016395,0.00028241682,0.012657728],"study_design_scores_gemma":[0.006925101,0.0007510156,0.97006285,0.0031972167,0.00020632372,0.000013483779,0.015238127,0.0017596717,0.0015413318,0.00008691574,0.0000409507,0.0001769879],"about_ca_topic_score_codex":0.0010548487,"about_ca_topic_score_gemma":0.0013925913,"teacher_disagreement_score":0.01248074,"about_ca_system_score_codex":0.00013254804,"about_ca_system_score_gemma":0.00014640807,"threshold_uncertainty_score":0.8002095},"labels":[],"label_agreement":null},{"id":"W4415671084","doi":"10.1177/20552173251390649","title":"Safety reporting quality in multiple sclerosis clinical trials: A review of phase III clinical trials included in FDA approval of disease-modifying treatments","year":2025,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; International Collaboration On Repair Discoveries; University of Toronto; University of British Columbia","funders":"","keywords":"Clinical trial; Multiple sclerosis; Quality (philosophy); Phase (matter); Phases of clinical research; MEDLINE; Fingolimod","score_opus":0.8083518433804945,"score_gpt":0.6390472112166301,"score_spread":0.16930463216386438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415671084","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025080638,0.9637163,0.00018987167,0.0005536159,0.0008965853,0.008151842,0.0013008269,0.000035680714,0.00007459291],"genre_scores_gemma":[0.072333746,0.9224226,0.0029767086,0.00018018796,0.00085685553,0.00047616108,0.00063347956,0.00008944849,0.000030806234],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.90065134,0.03411839,0.059726886,0.0020712756,0.0024479788,0.0009841212],"domain_scores_gemma":[0.8834473,0.08880281,0.024153605,0.0012055698,0.0007937688,0.0015969536],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"category_scores_codex":[0.15585293,0.0013118482,0.024339428,0.00093226484,0.0003441261,0.00007466241,0.0006647778,0.0012325556,0.00022260552],"category_scores_gemma":[0.20191403,0.0009630349,0.010624861,0.0012587593,0.0014221278,0.00036441765,0.00048160244,0.0036914337,0.0000040791733],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015895631,0.01706406,0.07451175,0.033751056,0.0036632621,0.000051403087,0.0001610526,0.000002939672,0.0001327277,0.000017780461,0.0001652845,0.854583],"study_design_scores_gemma":[0.15486223,0.0027780316,0.2163082,0.60479337,0.007938998,0.000040588286,0.00057179225,0.0010390873,0.00006407097,0.00006248915,0.010034156,0.0015069712],"about_ca_topic_score_codex":0.00021465642,"about_ca_topic_score_gemma":0.000072569506,"teacher_disagreement_score":0.8530761,"about_ca_system_score_codex":0.0004375875,"about_ca_system_score_gemma":0.0028470922,"threshold_uncertainty_score":0.9999633},"labels":[],"label_agreement":null}]}